<SEC-DOCUMENT>0001213900-25-084029.txt : 20250903
<SEC-HEADER>0001213900-25-084029.hdr.sgml : 20250903
<ACCEPTANCE-DATETIME>20250903160552
ACCESSION NUMBER:		0001213900-25-084029
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250902
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250903
DATE AS OF CHANGE:		20250903

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ACTELIS NETWORKS INC
		CENTRAL INDEX KEY:			0001141284
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMUNICATIONS EQUIPMENT, NEC [3669]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				522160309
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41375
		FILM NUMBER:		251289697

	BUSINESS ADDRESS:	
		STREET 1:		4039 CLIPPER COURT
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538
		BUSINESS PHONE:		510-545-1040

	MAIL ADDRESS:	
		STREET 1:		4039 CLIPPER COURT
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0255758-8k_actelis.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:ASNS="http://actelis.com/20250902">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03A_ASNS_actelis.com_20250902 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20250902_20250902 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001141284 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000004" name="dei:EntityCentralIndexKey">0001141284</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="asns-20250902.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-09-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001141284</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-09-02</xbrli:startDate>
        <xbrli:endDate>2025-09-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_900_edei--DocumentType_c20250902__20250902_zFcU99ESCvt7"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of report (Date of earliest event reported):
<b><span style="text-decoration: underline"><span id="xdx_903_edei--DocumentPeriodEndDate_c20250902__20250902_zUXL4JqZDQ79"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">September 2, 2025</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_904_edei--EntityRegistrantName_c20250902__20250902_zJg9Pkj3DpDj"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000011" name="dei:EntityRegistrantName">Actelis Networks, Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20250902__20250902_zviWpzyteX4c"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_900_edei--EntityFileNumber_c20250902__20250902_zTq5YmOzgMX6"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000013" name="dei:EntityFileNumber">001-41375</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_90A_edei--EntityTaxIdentificationNumber_c20250902__20250902_zaeoTzssLj29"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000014" name="dei:EntityTaxIdentificationNumber">52-2160309</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">(State or other jurisdiction <br/>
of incorporation)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(Commission File Number)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(I.R.S. Employer <br/>
Identification Number)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline"><span id="xdx_90C_edei--EntityAddressAddressLine1_c20250902__20250902_zYa6gNrsCoT8"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000015" name="dei:EntityAddressAddressLine1">4039 Clipper Court</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressCityOrTown_c20250902__20250902_zYwfOSylrlg6"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000016" name="dei:EntityAddressCityOrTown">Fremont</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressStateOrProvince_c20250902__20250902_z7idAkH3iYDe"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000017" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric></span> <span id="xdx_90A_edei--EntityAddressPostalZipCode_c20250902__20250902_zAqbaCI0uja4"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000018" name="dei:EntityAddressPostalZipCode">94538</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline"><span id="xdx_903_edei--CityAreaCode_c20250902__20250902_zTOYIXYiCXA"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000019" name="dei:CityAreaCode">(510)</ix:nonNumeric></span> <span id="xdx_909_edei--LocalPhoneNumber_c20250902__20250902_zbTIJeuAvoF"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000020" name="dei:LocalPhoneNumber">545-1045</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instructions A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--WrittenCommunications_c20250902__20250902_zHGgNvf4Fn34"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--SolicitingMaterial_c20250902__20250902_zRwY81zsl4Zj"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--PreCommencementTenderOffer_c20250902__20250902_zckbThei3EDd"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--PreCommencementIssuerTenderOffer_c20250902__20250902_zjqSQYidYgti"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 34%"><span style="font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_90A_edei--Security12bTitle_c20250902__20250902_zDstKIX8jNX5"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000025" name="dei:Security12bTitle">Common Stock, $0.0001 par value per share</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_90A_edei--TradingSymbol_c20250902__20250902_z8psAxSsJIaj"><ix:nonNumeric contextRef="AsOf2025-09-02" id="Fact000026" name="dei:TradingSymbol">ASNS</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_900_edei--SecurityExchangeName_c20250902__20250902_zDFLGtl2Lg32"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_edei--EntityEmergingGrowthCompany_c20250902__20250902_zxni7795cby2"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt:booleantrue" id="Fact000028" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_edei--EntityExTransitionPeriod_c20250902__20250902_zOpKsC5PaeUc"><ix:nonNumeric contextRef="AsOf2025-09-02" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 1.01 Entry into
a Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
September 2, 2025, Actelis Networks, Inc. (the &#8220;Company&#8221;) entered into an inducement agreement (the &#8220;Inducement Letter&#8221;)
with a certain holder (the &#8220;Holder&#8221;) of certain of the Company&#8217;s existing warrants to purchase an aggregate of 4,270,197
shares of the Company&#8217;s common stock, consisting of (i) 1,271,187 warrants issued on December 20, 2023 with an expiration date of
June 20, 2029 at an exercise price of $1.18 per share (ii) 999,670 warrants issued on June 6, 2024 with an expiration date of December
6, 2029 at an exercise price of $2.00 per share and (iii) 1,999,340 warrants issued on July 2, 2024 with an expiration date of July 2,
2026 at an exercise price of $1.75 per share (the &#8220;Existing Warrants&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Pursuant
to the Inducement Letter, the Holder agreed to exercise for cash the Existing Warrants to purchase an aggregate of 4,270,197 shares of
the Company&#8217;s common stock at a reduced exercise price of $0.37 per share in consideration of the Company&#8217;s agreement to issue
new common stock purchase warrants (the &#8220;New Warrants&#8221;), as descried below, to purchase up to an aggregate of 6,405,296 shares
of the Company&#8217;s common stock (the &#8220;New Warrant Shares&#8221;) at an exercise price of $0.37 per share. The Company expects
to receive aggregate gross proceeds of approximately $1.6 million from the exercise of the Existing Warrants by the Holder, before deducting
financial advisory fees and other offering expenses payable by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Rodman
&amp; Renshaw LLC and H.C. Wainwright &amp; Co., LLC (&#8220;Wainwright&#8221;) are acting as financial advisors to the Company in connection
with the transactions contemplated by the Inducement Letter. Pursuant to an engagement letter with Wainwright, the Company has agreed
to pay the financial advisors a cash fee equal to 7.0% of the aggregate gross proceeds received from the Holder&#8217;s exercise of the
Existing Warrants, as well as a management fee equal to 1.0% of the gross proceeds from the exercise of the Existing Warrants. The Company
has also agreed to issue to the financial advisors or their designees warrants (the &#8220;Placement Agent Warrants&#8221;) to purchase
up to 298,914 shares of common stock (representing 7.0% of the Existing Warrants being exercised), which will have the same terms as the
New Warrants having a term of five years of Stockholder Approval (as defined below) except the Placement Agent Warrants will have an exercise
price equal to $0.4625 per share (125% of the exercise price of the Existing Warrants).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
New Warrants will be exercisable from the date of Stockholder Approval (as defined below), until (i) the five-year anniversary of
such date for 3,406,286 of the New Warrants and (the &#8220;Series A-1 Warrants&#8221;) (ii) the two year anniversary of such date
for 2,999,010 of the New Warrants. The Placement Agent Warrants be exercisable from the date of Stockholder Approval, until the five
year anniversary of such date. In addition, the Company has also agreed to pay the Placement Agent up to $75,000 for
non-accountable, legal and other out-of-pocket expenses and $15,950 for clearing fees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
closing of the transactions contemplated pursuant to the Inducement Letter occurred on September 3, 2025 (the &#8220;Closing
Date&#8221;). The Company expects to use the net proceeds from these transactions for general corporate purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
resale of the shares of the Company&#8217;s common stock underlying the Existing Warrants have been registered pursuant to existing registration
statements on Form S-1, File Nos. 333-276425; 333-280434 and 333-281079, declared effective by the Securities and Exchange Commission
(the &#8220;SEC&#8221;) on April 4, 2024, June 27, 2024 and August 7, 2024, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Company also agreed to file a registration statement on Form S-1 (or other appropriate form if the Company is not then Form S-1
eligible) providing for the resale of the New Warrant Shares issued or issuable upon the exercise of the New Warrants (the
&#8220;Resale Registration Statement&#8221;), as soon as practicable after the Closing Date (and in any event within thirty (30)
calendar days of the date of Stockholder Approval), and to use commercially reasonable efforts to have such Resale Registration
Statement declared effective by the SEC within sixty (60) calendar days following the date of  Stockholder Approval (or within
ninety (90) calendar days following the date of  Stockholder Approval in case of &#8220;full review&#8221; of the Resale
Registration Statement by the SEC) and to keep the Resale Registration Statement effective at all times until no holder of the New
Warrants owns any New Warrants or New Warrant Shares. In the Inducement Letter, the Company agreed not to issue any shares of common
stock or common stock equivalents or to file any other registration statement with the SEC (in each case, subject to certain
exceptions) until 15 days after the Closing Date. The Company also agreed not to effect or agree to effect any Variable Rate
Transaction (as defined in the Inducement Letter) until one (1) year after the Closing Date (subject to certain
exceptions).&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
New Warrants, Placement Agent Warrants, the New Warrant Shares and the shares of common stock issuable upon the exercise of the Placement
Agent Warrants are being offered and sold pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities
Act of 1933, as amended (the &#8220;Securities Act&#8221;). The Holder has represented that it is an accredited investor as defined in
Rule 501 of the Securities Act and has acquired such securities for their own account and has no arrangements or understandings for any
distribution thereof. The offer and sale of the foregoing securities is being made without any form of general solicitation or advertising.
The New Warrants, Placement Agent Warrants, the New Warrant Shares and the shares of common stock issuable upon the exercise of the Placement
Agent Warrants have not been registered under the Securities Act or applicable state securities laws. Accordingly, such securities may
not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the
registration requirements of the Securities Act and such applicable state securities laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">This
Current Report on Form 8-K shall not constitute an offer to sell or the solicitation to buy nor shall there be any sale of the securities
in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under
the securities laws of any such state or jurisdiction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Immediately
prior to the transactions contemplated by the Inducement Letter, the number of shares of the Company&#8217;s common stock that was
issued and outstanding was 11,292,114. After giving effect to the transactions contemplated by the Inducement Letter, including the
closing thereof, the number of shares of the Company&#8217;s common stock that will be issued and outstanding is 12,545,117, which
reflects the fact that 3,017,197 of the shares issuable upon exercise of the Existing Warrants are being held in abeyance at the
time of closing to adhere with beneficial ownership limitation mechanisms set forth in the Existing Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Terms of the New Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
following summary of certain terms and provisions of the New Warrants is not complete and is subject to, and qualified in its entirety
by, the provisions of the New Warrants, the form of which is filed as Exhibit 10.2 to this Current Report on Form 8-K and is incorporated
herein by reference. The following description of the New Warrants is qualified in its entirety by reference to such exhibit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><i>Duration
and Exercise Price</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
New Warrant will have an exercise price equal to $0.37 per share. The New Warrants will be exercisable from the date of Stockholder Approval
(defined below), until (i) the five-year anniversary of such date for 3,406,286 of the New Warrants and (ii) the twenty-four-month anniversary
of such date for 2,999,010 of the New Warrants. The exercise price and number of New Warrant Shares issuable upon exercise of the New
Warrants is subject to appropriate adjustment in the event of stock dividends, stock splits, subsequent rights offerings, pro rata distributions,
reorganizations, or similar events affecting the Company&#8217;s common stock and the exercise price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><i>Stockholder
Approval</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in">The
New Warrants will be exercisable commencing on the effective date of shareholder approval (&#8220;Stockholder Approval&#8221;). The Company
has agreed to hold a meeting of its stockholders on or prior to the date that is ninety (90) days following the Closing Date for the purpose
of obtaining Stockholder Approval.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><i>Exercisability</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
New Warrants will be exercisable, at the option of each holder, in whole or in part, by delivering to the Company a duly executed exercise
notice accompanied by payment in full for the number of shares of the Company&#8217;s common stock purchased upon such exercise (except
in the case of a cashless exercise as discussed below). A holder (together with its affiliates) may not exercise any portion of such holder&#8217;s
New Warrants to the extent that the holder would own more than 4.99% (or, at the election of the holder, 9.99%) of the outstanding common
stock immediately after exercise, except that upon prior notice from the holder to the Company, the holder may increase or decrease the
amount of ownership of outstanding stock after exercising the holder&#8217;s New Warrants up to 9.99% of the number of shares of the Company&#8217;s
common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with
the terms of the New Warrants, provided that any increase will not be effective until 61 days following notice to the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Cashless Exercise</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If,
at the time a holder exercises its New Warrants, a registration statement registering the resale of the New Warrant Shares by the holder
under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) is not then effective or available, then in lieu of making
the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the aggregate exercise price, the holder
may elect instead to receive upon such exercise (either in whole or in part), the net number of shares of common stock determined according
to a formula set forth in the New Warrants.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><i>Trading
Market</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">There
is no established trading market for the New Warrants, and the Company does not expect an active trading market to develop. The Company
does not intend to apply to list the New Warrants on any securities exchange or other trading market. Without a trading market, the liquidity
of the New Warrants will be extremely limited.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><i>Rights
as a Stockholder</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Except
as otherwise provided in the New Warrants or by virtue of the holder&#8217;s ownership of shares of the Company&#8217;s common stock,
such holder of New Warrants does not have the rights or privileges of a holder of the Company&#8217;s common stock, including any voting
rights, until such holder exercises such holder&#8217;s New Warrants. The New Warrants will provide that the holders of the New Warrants
have the right to participate in distributions or dividends paid on shares of the Company&#8217;s common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><i>Fundamental
Transactions</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If
at any time the New Warrants are outstanding, the Company, either directly or indirectly, in one or more related transactions effect a
Fundamental Transaction (as defined in the New Warrants), a holder of New Warrants will be entitled to receive, the number of shares of
common stock of the successor or acquiring corporation or of the Company, if the Company is the surviving corporation, and any additional
consideration receivable as a result of the Fundamental Transaction by such holder of the number of shares of common stock for which the
New Warrants are exercisable immediately prior to the Fundamental Transaction. As an alternative, with respect to the Series A-1 Warrants
and Placement Agent Warrants, in the event of a Fundamental Transaction, the holders thereof may, at their option, exercisable at any
time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the public
announcement of the applicable fundamental transaction), cause the Company to purchase the unexercised portion of the Series A-1 Warrants
or Placement Agent Warrants, as applicable, from the holder by paying to the holder an amount of cash equal to the Black Scholes Value
(as defined in the Series A-1 Warrants) of the remaining unexercised portion of such warrants on the date of the consummation of such
Fundamental Transaction.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><i>Waivers
and Amendments</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
New Warrants may be modified or amended or the provisions of the New Warrants waived with the Company&#8217;s and the holder&#8217;s written
consent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
forms of Inducement Letter, New Warrants and Placement Agent Warrants are attached as Exhibits 10.1, 10.2 and 10.3, respectively. The
description of the terms of the Inducement Letter and the New Warrants are not intended to be complete and are qualified in its entirety
by reference to such exhibits. The Inducement Letter contains customary representations, warranties and covenants by the Company which
were made only for the purposes of such agreements and as of specific dates, were solely for the benefit of the parties to such agreements
and may be subject to limitations agreed upon by the contracting parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 3.02 Unregistered Sales of Equity Securities.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
information under Item 1.01 of this Current Report on Form 8-K regarding the unregistered securities described therein is incorporated
herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Warning Concerning Forward Looking Statements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Current Report on Form
8-K contains statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act
of 1995 and other securities laws. These forward looking statements are based upon the Company&#8217;s present intent, beliefs or expectations,
but forward looking statements are not guaranteed to occur and may not occur for various reasons, including some reasons which are beyond
the Company&#8217;s control. For this reason, among others, you should not place undue reliance upon the Company&#8217;s forward looking
statements. Except as required by law, the Company undertakes no obligation to revise or update any forward looking statements in order
to reflect any event or circumstance that may arise after the date of this Current Report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9.01. Financial Statement and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(d) Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 9%"><span style="font-size: 10pt">Exhibit No.</span></td>
    <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 90%"><span style="font-size: 10pt">Description</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt"><a href="ea025575801ex10-1_actelis.htm">Form of Inducement Letter</a></span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">10.2</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt"><a href="ea025575801ex10-2_actelis.htm">Form of New Warrant</a></span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">10.3</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt"><a href="ea025575801ex10-3_actelis.htm">Form of Placement Agent Warrant</a></span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.45in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.8in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-size: 10pt"><b>ACTELIS NETWORKS, INC.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%"><span style="font-size: 10pt">Dated: September 3, 2025</span></td>
    <td style="width: 5%"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; width: 35%"><span style="font-size: 10pt">/s/ Tuvia Barlev</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Name: </span></td>
    <td><span style="font-size: 10pt">Tuvia Barlev</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Title:</span></td>
    <td><span style="font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKwjAMRb9g/xD6LNoNFLZHxxRxigwRX6uLUtyakda5fZJ/ad0QQyAk955cISZiTStdIcN5WeRwxLqplEMo8IaM5orekW62CfhZ4F1bx8q4Yf2BKXkGPbOYhhd/H5yttlgmIOOZjGbRHEKZyBgOOxF89ZTMTZdonFYVKFPCgalhjU5xP344qo4M1f2QdEK2mkwC4VSO8hsiGUawp1a9iB8W8jwVwWSoQKyZno13ZZ1D8yUhq7D2cXak/x18AMwASl0= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ea025575801ex10-1_actelis.htm
<DESCRIPTION>FORM OF INDUCEMENT LETTER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Actelis
Networks, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 328.5pt; text-align: right">September 2, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Holder of Common Stock Purchase Warrants</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Inducement
Offer to Exercise Common Stock Purchase Warrants</U></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Holder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Actelis Networks, Inc. (the
&ldquo;<U>Company</U>&rdquo;) is pleased to offer to you (&ldquo;<U>Holder</U>&rdquo;, &ldquo;<U>you</U>&rdquo; or similar terminology)
the opportunity to receive (i) new warrants to purchase shares of the Company&rsquo;s common stock, par value $0.0001 per share (the &ldquo;<U>Common
Stock</U>&rdquo;), and (ii) a reduction of the Exercise Price (as defined in the respective Existing Warrants (as defined herein)) of
certain warrants to purchase shares of Common Stock held by you as set forth on Exhibit A hereto (the &ldquo;<U>Existing Warrants</U>&rdquo;)
in consideration for exercising for cash all such Existing Warrants, as more particularly set forth on the signature page hereto. The
resale of the shares of Common Stock underlying the Existing Warrants has been registered pursuant to the registration statements on Form
S-1 (File Nos. 333-276425, 333-280434 and 333-281079). The shares of Common Stock underlying the Existing Warrants are collectively referred
to herein as the &ldquo;Warrant Shares&rdquo; and the registration statements referenced in the foregoing sentence are referred to herein
as the &ldquo;Registration Statements.&rdquo; The Registration Statements are currently effective and, upon exercise of the Existing Warrants
pursuant to this letter agreement, will be effective for the issuance or resale of the Warrant Shares, as applicable. Capitalized terms
not otherwise defined herein shall have the meanings set forth in the New Warrants (as defined herein).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company desires to reduce
the Exercise Price of the Existing Warrants to $0.37 per share (the &ldquo;<U>Reduced Exercise Price</U>&rdquo;). In consideration for
exercising in full all of the Existing Warrants held by Holder as set forth on the Holder&rsquo;s signature page hereto (the &ldquo;<U>Warrant
Exercise</U>&rdquo;) on or before the Execution Time (as defined herein), the Company hereby offers to sell and issue you new unregistered
Common Stock purchase warrants (the &ldquo;<U>New Warrants</U>&rdquo;) pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended
(&ldquo;<U>Securities Act</U>&rdquo;), to purchase up to a number of shares (the &ldquo;<U>New Warrant Shares</U>&rdquo;) of Common Stock
equal to 150% of the number of Warrant Shares issued pursuant to the Warrant Exercise hereunder, which New Warrants shall be substantially
in the form as set forth <U>in Exhibit A</U> hereto, will be exercisable at any time on or after the Stockholder Approval Date and expire,
with respect to Series A-1 warrants to purchase up to 3,406,286 shares of Common Stock, five (5) years from the Stockholder Approval Date
and with respect to Series A-2 warrants to purchase up to 2,999,010 shares of Common Stock, twenty-four (24) months from the Stockholder
Approval Date, and shall have an exercise price per share equal to $0.37, subject to adjustments as provided in the New Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The New Warrant certificate(s)
will be delivered at Closing (as defined below), and such New Warrants, together with any underlying shares of Common Stock issued upon
exercise of the New Warrants, will, unless and until their sales are registered under the Securities Act, contain customary restrictive
legends and other language typical for an unregistered warrant and unregistered shares. Notwithstanding anything herein to the contrary,
in the event that any Warrant Exercise would otherwise cause the Holder to exceed the beneficial ownership limitations (&ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo;) set forth in Section 2(e) of the Existing Warrants (or, if applicable and at the Holder&rsquo;s election,
9.99%), the Company shall only issue such number of Existing Warrant Shares to the Holder that would not cause the Holder to exceed the
maximum number of Warrant Shares permitted thereunder, as directed by the Holder, with the balance to be held in abeyance until notice
from the Holder that the balance (or portion thereof) may be issued in compliance with such limitations, which abeyance shall be evidenced
through the Existing Warrants which shall be deemed prepaid thereafter (including the cash payment in full of the exercise price), and
exercised pursuant to a Notice of Exercise in the Existing Warrants (provided no additional exercise price shall be due and payable).
The parties hereby agree that the Beneficial Ownership Limitation for purposes of the Existing Warrants is as set forth on the Holder&rsquo;s
signature page hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Expressly
subject to the paragraph immediately following this paragraph below, Holder may accept this offer by signing this letter agreement below,
with such acceptance constituting Holder&rsquo;s exercise in full of the Existing Warrants for an aggregate exercise price set forth on
the Holder&rsquo;s signature page hereto (the &ldquo;<U>Warrant Exercise Price</U>&rdquo;) on or before 1:45 p.m., Eastern Time, on September
2, 2025 (the &ldquo;<U>Execution Time</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, the Company
agrees to the representations, warranties and covenants set forth on&nbsp;<U>Annex A</U>&nbsp;attached hereto. Holder represents and warrants
that, as of the date hereof it is, and on each date on which it exercises any New Warrants it will be, an &ldquo;accredited investor&rdquo;
as defined in Rule 501 of Regulation D promulgated under the Securities Act, and agrees that the New Warrants will contain restrictive
legends when issued, and neither the New Warrants nor the shares of Common Stock issuable upon exercise of the New Warrants will be registered
under the Securities Act, except as provided in&nbsp;<U>Annex A</U>&nbsp;attached hereto. Also, Holder represents and warrants that it
is acquiring the New Warrants as principal for its own account and has no direct or indirect arrangement or understandings with any other
persons to distribute or regarding the distribution of the New Warrants or the New Warrant Shares (this representation is not limiting
Holder&rsquo;s right to sell the New Warrant Shares pursuant to an effective registration statement under the Securities Act or otherwise
in compliance with applicable federal and state securities laws).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Holder understands that
issuance of the New Warrants and the New Warrant Shares are not, and may never be, registered under the Securities Act, or the securities
laws of any state and, accordingly, each certificate, if any, representing such securities shall bear a legend substantially similar to
the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&ldquo;THE OFFER
AND SALE OF THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE
IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND,
ACCORDINGLY, THIS SECURITY MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT
OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND
IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certificates evidencing the
New Warrant Shares shall not contain any legend (including the legend set forth above), (i) while a registration statement covering the
resale of such New Warrant Shares is effective under the Securities Act, (ii) following any sale of such New Warrant Shares pursuant to
Rule 144 under the Securities Act, (iii) if such New Warrant Shares are eligible for sale under Rule 144 (assuming cashless exercise of
the New Warrants), without the requirement for the Company to be in compliance with the current public information required under Rule
144 as to such New Warrant Shares and without volume or manner-of-sale restrictions, (iv)&nbsp;if such New Warrant Shares may be sold
under Rule 144 (assuming cashless exercise of the New Warrants) and the Company is then in compliance with the current public information
required under Rule 144 as to such New Warrant Shares, or (v) if such legend is not required under applicable requirements of the Securities
Act (including judicial interpretations and pronouncements issued by the staff of the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;)
and the earliest of clauses (i) through (v), the &ldquo;<U>Delegend Date</U>&rdquo;)). The Company shall cause its counsel to issue a
legal opinion to the Transfer Agent promptly after the Delegend Date if required by the Company and/or the Transfer Agent to effect the
removal of the legend hereunder, or at the request of the Holder, which opinion shall be in form and substance reasonably acceptable to
the Holder. From and after the Delegend Date, such New Warrant Shares shall be issued free of all legends. The Company agrees that following
the Delegend Date or at such time as such legend is no longer required under this Section, it will, no later than one (1) Trading Day
following the delivery by the Holder to the Company or the Transfer Agent of a certificate representing the New Warrant Shares issued
with a restrictive legend (such first (1st) Trading Day, the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver or cause to be delivered
to the Holder a certificate representing such shares that is free from all restrictive and other legends or, at the request of the Holder
shall credit the account of the Holder&rsquo;s prime broker with the Depository Trust Company System as directed by the Holder. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to the Holder&rsquo;s
other available remedies, the Company shall pay to a Holder, in cash, (i) as partial liquidated damages and not as a penalty, for each
$1,000 of New Warrant Shares (based on the VWAP of the Common Stock on the date such New Warrant Shares are submitted to the Transfer
Agent) delivered for removal of the restrictive legend, $10 per Trading Day (increasing to $20 per Trading Day five (5) Trading Days after
such damages have begun to accrue) for each Trading Day after the Legend Removal Date until such certificate is delivered without a legend
and (ii) if the Company fails to (a) issue and deliver (or cause to be delivered) to the Holder by the Legend Removal Date a certificate
representing the New Warrant Shares that is free from all restrictive and other legends and (b) if after the Legend Removal Date the Holder
purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Holder of all
or any portion of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of
the number of shares of Common Stock that the Holder anticipated receiving from the Company without any restrictive legend, then, an amount
equal to the excess of the Holder&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any)
for the shares of Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) over the product
of (A) such number of New Warrant Shares that the Company was required to deliver to the Holder by the Legend Removal Date and for which
the Holder was required to purchase shares to timely satisfy delivery requirements, multiplied by (B) the weighted average price at which
the Holder sold that number of shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If this offer is accepted
and the transaction documents are executed by the Execution Time, then as promptly as possible following the Execution Time, but in any
event no later than 2:30 p.m. Eastern Time on the date hereof, the Company shall issue a press release disclosing the material terms of
the transactions contemplated hereby and, within the time required by the Exchange Act, shall file a Current Report on Form 8-K with the
Commission disclosing all material terms of the transactions contemplated hereunder, including the filing with the Commission of this
letter agreement as an exhibit thereto. From and after the dissemination of such press release, the Company represents to you that it
shall have publicly disclosed all material, non-public information delivered to you by the Company, or any of its respective officers,
directors, employees or agents in connection with the transactions contemplated hereunder. In addition, effective upon the dissemination
of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement,
whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees
or Affiliates on the one hand, and you and your Affiliates on the other hand, shall terminate. The Company represents, warrants and covenants
that, upon acceptance of this offer, the Warrant Shares shall be issued at Closing free of any legends or restrictions on resale by Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No later than the first (1st)
Trading Day following the date hereof (or the second (2nd) Trading Day following the date hereof if this letter agreement is signed on
a day that is not a Trading Day or after 4:00 p.m. (New York City time) and before midnight (New York City time) on a Trading Day), the
closing (&ldquo;Closing&rdquo;) shall occur at such location as the parties shall mutually agree. Settlement of the Warrant Shares shall
occur via DWAC, i.e., on the Closing Date (as defined below), the Holder shall deliver the payment for the Aggregate Warrant Exercise
Price by wire transfer to the Company. Upon receipt of the Aggregate Exercise Price, the Company shall issue the Warrant Shares registered
in the Holder&rsquo;s name and address provided to the Company in writing and released by the Transfer Agent directly to the account identified
by the Holder. The date of the Closing of the Warrant Exercise shall be referred to as the &ldquo;<U>Closing Date</U>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company shall pay all
transfer agent fees, stamp taxes and other taxes and duties levied in connection with the delivery of any Exiting Warrant Shares. This
letter agreement shall be construed and enforced in accordance with the laws of the State of New York, without regards to conflicts of
laws principles. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City
of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated
hereby.</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Actelis Networks, Inc.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: black 1.5pt solid; text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Holder Signature Page Follows]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accepted and Agreed to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Holder: ________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Holder</I>:
_________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: _______________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Number of Existing Warrants: __________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Aggregate Warrant Exercise Price being exercised
contemporaneously with signing this letter agreement: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Existing Warrants Beneficial Ownership Blocker:
&#9744; 4.99% or &#9744; 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">New Warrants: _______________ (150% of the total
Existing Warrants being exercised)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">New Warrants Beneficial Ownership Blocker: &#9744;
4.99% or &#9744; 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DTC Instructions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Holder signature page to ASNS Inducement Offer]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Annex A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Representations, Warranties
and Covenants of the Company</U>. The Company hereby makes the following representations and warranties to the Holder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SEC
Reports</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company
under the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the one year preceding the date hereof (or such shorter
period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto
and documents incorporated by reference therein &ldquo;<U>SEC Reports</U>&rdquo;). As of their respective dates, the SEC Reports complied
in all material respects with the requirements of the Exchange Act and none of the SEC Reports, when filed, contained any untrue statement
of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading. The Company is not currently an issuer identified in Rule
144(i) under the Securities Act.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this letter agreement and otherwise to carry out its obligations hereunder. The execution and delivery of this letter agreement by
the Company and the consummation by the Company of the transactions contemplated hereby have been duly authorized by all necessary action
on the part of the Company and no further action is required by the Company, its board of directors or its stockholders in connection
herewith. This letter agreement has been duly executed by the Company and, when delivered in accordance with the terms hereof, will constitute
the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by
general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No
Conflicts</U>. The execution, delivery and performance of this letter agreement by the Company and the consummation by the Company of
the transactions contemplated hereby do not and will not: (i) conflict with or violate any provision of the Company&rsquo;s certificate
or articles of incorporation, bylaws or other organizational or charter documents; or (ii) conflict with, or constitute a default (or
an event that with notice or lapse of time or both would become a default) under, result in the creation of any &nbsp;liens, claims,
security interests, other encumbrances or defects upon any of the properties or assets of the Company in connection with, or give to
others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any material
agreement, credit facility, debt or other material instrument (evidencing Company debt or otherwise) or other material understanding
to which such Company is a party or by which any property or asset of the Company is bound or affected; or (iii) conflict with or result
in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority
to which the Company is subject (including federal and state securities laws and regulations), or by which any property or asset of the
Company is bound or affected, except, in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected
to result in a material adverse effect upon the business, prospects, properties, operations, condition (financial or otherwise) or results
of operations of the Company, taken as a whole, or in its ability to perform its obligations under this letter agreement.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Registration
Obligations</U>. As soon as reasonably practicable (and in any event within thirty (30) calendar days of the Stockholder Approval Date),
the Company shall file a registration statement on Form S-3 (or other appropriate form, including on Form S-1, if the Company is not
then S-3 eligible) providing for the resale of the New Warrant Shares by the holders of the New Warrants (the &ldquo;<U>Resale Registration
Statement</U>&rdquo;). The Company shall use commercially reasonable efforts to cause the Resale Registration Statement to become effective
within sixty (60) calendar days following the date Stockholder Approval is received (or within ninety (90) calendar days following the
date Stockholder Approval is received in case of &ldquo;full review&rdquo; of such registration statement by the Commission) and to keep
the Resale Registration Statement effective at all times until no holder of the New Warrants owns any New Warrants or New Warrant Shares.</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Trading
Market</U>. Except for as related to the Stockholder Approval, &nbsp;the transactions contemplated under this letter agreement comply
with all the rules and regulations of the Nasdaq Capital Market.</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in
connection with the execution, delivery and performance by the Company of this letter agreement, other than: (i) the filings required
pursuant to this letter agreement, (ii) application(s) or notice to each applicable Trading Market for the listing of the New Warrants
and New Warrant Shares for trading thereon in the time and manner required thereby, (iii) the filing of Form D with the Commission, (iv)
such filings as are required to be made under applicable state securities laws and (v) Stockholder Approval.</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Listing
of Common Stock</U>. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock on the Trading
Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of the New Warrant
Shares on such Trading Market and promptly secure the listing of all of the New Warrant Shares on such Trading Market. The Company further
agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application
all of the New Warrant Shares, and will take such other action as is necessary to cause all of the New Warrant Shares to be listed or
quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably necessary to continue the
listing and trading of its Common Stock on a Trading Market and will comply in all respects with the Company&rsquo;s reporting, filing
and other obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility of the Common Stock
for electronic transfer through the Depository Trust Company or another established clearing corporation, including, without limitation,
by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic
transfer. In addition, the Company shall hold an annual or special meeting of its stockholders on or prior to the date that is ninety
(90) days following the Closing Date for the purpose of obtaining Stockholder Approval, with the recommendation of the Company&rsquo;s
Board of Directors that such proposals are approved, and the Company shall solicit proxies from its stockholders in connection therewith
in the same manner as all other management proposals in such proxy statement and all management-appointed proxyholders shall vote their
proxies in favor of such proposals. If the Company does not obtain Stockholder Approval at the first meeting, the Company shall call
a meeting every ninety (90) days thereafter to seek Stockholder Approval until the earlier of the date on which Stockholder Approval
is obtained or the New Warrants are no longer outstanding. The Holder covenants that if it holds any Warrant Shares as of the record
date of such meeting, the Holder shall not vote such Warrant Shares on the proposal for Stockholder Approval at such meeting.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Subsequent
Equity Sales</U>.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: justify">(i) From the date hereof until fifteen (15)
days after the Closing Date, neither the Company nor any Subsidiary shall (A) issue, enter into any agreement to issue or announce the
issuance or proposed issuance of any Common Stock or Common Stock Equivalents or (B) file any registration statement or any amendment
or supplement to any existing registration statement (other than the Resale Registration Statement referred to herein or any prospectus
supplement in connection with the transactions contemplated hereby or any registration statement on Form S-8 in connection with any employee
benefit plan). Notwithstanding the foregoing, this Section (h)(i) shall not apply in respect of an Exempt Issuance. &ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company pursuant
to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority
of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) warrants
to the financial advisors in connection with the transactions pursuant to this letter agreement and any securities upon exercise of warrants
to the financial advisors, securities upon the exercise or exchange of or conversion of any securities issued hereunder and/or other
securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this letter
agreement, provided that such securities have not been amended since the date of this letter agreement to increase the number of such
securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with stock
splits or combinations) or to extend the term of such securities, and (c) securities issued pursuant to acquisitions or strategic transactions
approved by a majority of the disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo;
(as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection
therewith during the prohibition period in this Section (h)(i), and provided that any such issuance shall only be to a Person (or to
the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business
synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds,
but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an
entity whose primary business is investing in securities.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: justify">(ii) From the date hereof
    until one (1) year following the Closing Date, the Company shall be prohibited from effecting or entering into an agreement to effect
    any issuance by the Company nor any Subsidiary of Common Stock or Common Stock Equivalents (or a combination of units thereof) involving
    a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction in which the Company (i) issues or sells
    any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive, additional
    shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is based upon, and/or varies
    with, the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such debt or equity
    securities or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance
    of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related to the business
    of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction under, any agreement, including, but not
    limited to, an equity line of credit or an &ldquo;at-the-market offering&rdquo;, whereby the Company may issue securities at a future
    determined price, regardless of whether shares pursuant to such agreement have actually been issued and regardless of whether such agreement
    is subsequently canceled;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that, following the expiration of the restrictive period set forth
    in Section (h)(i) above, the entry into and/or issuance of shares of Common Stock in an &ldquo;at the market&rdquo; offering with H.C.
    Wainwright &amp; Co., LLC as sales agent shall not be deemed a Variable Rate Transaction. The Holder shall be entitled to obtain injunctive
    relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Form D; Blue Sky Filings</U>. If required, the Company agrees to timely file a Form D with respect to the New Warrants and New Warrant Shares as required under Regulation D and to provide a copy thereof, promptly upon request of any Holder. The Company shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the New Warrants and New Warrant Shares for, sale to the Holder at Closing under applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States, and shall provide evidence of such actions promptly upon request of any Holder.</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXHIBIT A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXISTING WARRANTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">-</FONT></TD><TD STYLE="text-align: justify">1,271,187 shares of common stock issuable upon the exercise
of warrants issued on 12/20/2023:</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify">Exercise price per share&ndash; $1.18</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify">Expiration Date &ndash; 5.5 years from the date of issuance</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">-</FONT></TD><TD STYLE="text-align: justify">999,670 shares of common stock issuable upon the exercise
of warrants issued on June 5, 2024:</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify">Exercise price per share &ndash; $2.00</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify">Expiration Date &ndash; 5.5 years from date of issuance</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">-</FONT></TD><TD STYLE="text-align: justify">1,999,340 shares of common stock issuable upon exercise of
warrants issued on July 2, 2024:</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify">Exercise price per share &ndash; $1.75</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify">Expiration date &ndash; 24 months from date of issuance</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">8</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ea025575801ex10-2_actelis.htm
<DESCRIPTION>FORM OF NEW WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">NEITHER THIS SECURITY NOR THE SECURITIES
FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF
ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">SERIES [A-1/A-2] COMMON STOCK
PURCHASE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">WARRANT ACTELIS NETWORKS, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 55%">Warrant Shares: [____]</TD>
  <TD STYLE="text-align: right; width: 45%">Issue Date:
[_____], 2025</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 1in">THIS SERIES [A-1/A-2]
COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, [_________], or its assigns (the
&ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set
forth, at any time on or after the Stockholder Approval Date (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00
p.m. (New York City time) on [_______]<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT>
anniversary of the Initial Exercise Date, provided that, if such date is not a Trading Day, the date that is the immediately following
Trading Day (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Actelis Networks, Inc.,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to [_________] shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant
Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise
Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><U>Section 1</U>.
<U>Definitions</U>. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this
Section 1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&ldquo;<U>Board of Directors</U>&rdquo; means the board of
directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any
other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so
long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally are
open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;<U>Commission</U>&rdquo; means
the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT></TD><TD STYLE="text-align: justify">Insert: five (5) years for Series A-1 and twenty-four (24)
months for Series A-2.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Letter
Agreement</U>&rdquo; means that certain letter agreement between the initial Holder hereof and the Company, dated as of September 2, 2025,
pursuant to which such initial Holder agreed to exercise one or more warrants to purchase shares of Common Stock and the Company agreed
to issue to the initial Holder this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Stockholder
Approval</U>&rdquo; means such approval as may be required by the applicable rules and regulations of the Nasdaq Capital Market (or any
successor entity) from the stockholders of the Company with respect to issuance of all of the Warrants and the Warrant Shares upon the
exercise thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Stockholder
Approval Date</U>&rdquo; means the date on which Stockholder Approval is received and deemed effective under Delaware law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;<U>Trading Day</U>&rdquo; means
a day on which the Common Stock is traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0 0pt 0in; text-align: justify">&ldquo;<U>Trading Market</U>&rdquo;
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the
NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or
any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means VStock Transfer, LLC, the current transfer agent of the Company, with a mailing address of 18 Lafayette Place,
Woodmere, NY 11598, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Common Stock purchase warrants issued by the Company pursuant to the Letter Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within
the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section
2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares
specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless
exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise
shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required.
Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company
until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case,
the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable following the date on which
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise
within one (1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and
agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number
of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$0.37</B>, subject to adjustment hereunder (the
&ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part,
at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares
equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(A)&nbsp;=&nbsp;</TD><TD STYLE="text-align: justify">as applicable: (i) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section
2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior
to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities
laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported
by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise
if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours
thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section
2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day
and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo;
on such Trading Day;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(B)&nbsp;=&nbsp; </TD><TD STYLE="text-align: justify">the Exercise Price of this Warrant, as adjusted hereunder;
and</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(X)&nbsp;=&nbsp; </TD><TD STYLE="text-align: justify">the number of Warrant Shares that would be issuable upon exercise
of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless
exercise.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><U>&ldquo;Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City
time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common
Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted
for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)
in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith
by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and
expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act,
the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to
take any position contrary to this Section 2(c).</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in; text-align: justify">d)
<U>Mechanics of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.25in">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust
Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such
system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the
Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations
pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in
the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is
entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier of
(i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and (ii) the number of Trading Days comprising the
Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery
Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder
of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant
Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by the Warrant
Share Delivery Date. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise
by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each
$1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise),
$10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading
Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees
to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As
used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days,
on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of
Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.25in">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 26.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.25in">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 23pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.25in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its
broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common
Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise
(a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained
by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise
at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the
Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in
which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been
issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common
Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with
an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the
Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable
to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit
a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree
of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock
upon exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 23.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.25in">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.25in">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.25in">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 20.25pt"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 20.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other
securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the
number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with
the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company
or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the
Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of
securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such
number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be [4.99%/9.99%]
of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable
upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions
of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of Common Stock
outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder
and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective
until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented
in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof)
which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements
necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor
holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><U>Section 3</U>. <U>Certain Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective
date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the
record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>,
that to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership
of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance
for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related
transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary),
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or
substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender
offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are
permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of
more than 50% of the outstanding Common Stock or more than 50% of the voting power of the common equity of the Company, (iv) the
Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or
recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted
into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related
transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a
reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such
other Person or group acquires more than 50% of the outstanding shares of Common Stock or more than 50% of the voting power of the
common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this
Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise
immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation
in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or
of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate
Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock
for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section
2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the average amount of Alternate Consideration issuable per
shareholder in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise
Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the
Alternate Consideration. [Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any
Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within 30
days after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable
Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes
Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental
Transaction; provided, however, that, if the Fundamental Transaction is not within the Company&rsquo;s control, including not
approved by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive from the Company or any Successor
Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of
this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental
Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common
Stock are given the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction;
provided, further, that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental
Transaction, such holders of Common Stock will be deemed to have received common stock of the Successor Entity (which Entity may be
the Company following such Fundamental Transaction) in such Fundamental Transaction. &ldquo;Black Scholes Value&rdquo; means the
value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg
determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a
risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public
announcement of the applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to
the volatility for the remaining exercised period as obtained from the HVT function on Bloomberg (determined utilizing a 252 day
annualization factor) as of the Trading Day immediately following the consummation of the applicable contemplated Fundamental
Transaction, (C) the underlying price per share used in such calculation shall be the VWAP for the 30 days prior to the Trading Day
immediately preceding the consummation of the applicable contemplated Fundamental Transaction and (D) a remaining option time equal
to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination
Date and (E) cost of borrow for the company&rsquo;s stock at the exercise date. The payment of the Black Scholes Value will be made
by wire transfer of immediately available funds (or such other consideration) within the later of (i) five Business Days of the
Holder&rsquo;s election and (ii) the date of consummation of the Fundamental Transaction.]<FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>2</SUP></FONT>
The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the
&ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant in accordance
with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder
and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the
Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument
substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital
stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon
exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction,
and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the
relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock,
such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this
Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and
substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term
&ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
each and every provision of this Warrant referring to the &ldquo;Company&rdquo; shall refer instead to each of the Company and the
Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and
severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor
Entities shall assume all of the obligations of the Company prior thereto under this Warrant with the same effect as if the Company
and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein. For the avoidance of
doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(d) regardless of (i) whether the Company has
sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction occurs
prior to the Initial Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>2</SUP></FONT></TD><TD STYLE="text-align: justify">Language in brackets to be included on Series A-1 only.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in; text-align: justify">f)
<U>Notice to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.25in">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.25in">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled
to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non- public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><U>Section 4</U>. <U>Transfer of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof, this Warrant and all rights
hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant
at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the
form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon
the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or
Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant
shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant
to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this
Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant
Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be identical with
this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, provides to the Company an opinion of counsel, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that the transfer of this Warrant does not require registration under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0.5in; text-align: justify">d)
<U>Authorized Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough
of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.
Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in
such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo; fees and other costs and
expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder
in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice
of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service, addressed
to the Company, at [_______________], Attention: Tuvia Barlev, email address: tuvia.barlev@actelis.com, or such other email address or
address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other communications or deliveries
to be provided by the Company hereunder shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight
courier service addressed to each Holder at the e-mail address or address of such Holder appearing on the books of the Company. Any notice
or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if
such notice or communication is delivered via e-mail at the e-mail address set forth in this Section prior to 5:30 p.m. (New York City
time) on any date, (ii) the next Trading Day after the time of transmission, if such notice or communication is delivered via e-mail at
the e-mail address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading
Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv)
upon actual receipt by the party to whom such notice is required to be given. To the extent that any notice provided hereunder constitutes,
or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice
with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder of this Warrant, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15pt; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 71.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.5in">IN WITNESS WHEREOF, the Company has
caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>ACTELIS NETWORKS, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 3%"></TD>
    <TD STYLE="font-size: 10pt; width: 5%">Name:</TD>
    <TD STYLE="font-size: 10pt; width: 32%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"></TD>
    <TD STYLE="font-size: 10pt">Title:</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3pt; text-align: center">NOTICE OF EXERCISE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">TO: <B>ACTELIS NETWORKS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">(1) The undersigned
hereby elects to purchase _______Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and
tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0.5in; text-align: justify">(2)
Payment shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-indent: 0in; text-align: justify">&#9744; in lawful money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-indent: 0in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#9744; if permitted the cancellation
of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant
with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: 1in; text-align: left; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">The Warrant Shares shall be delivered to the following DWAC
Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: 1in; text-align: left; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: 1in; text-align: left; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: 1in; text-align: left; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.5in">(4) <U>Accredited
Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act
of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">[SIGNATURE OF HOLDER]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 17%">Name of Investing Entity: </TD>
  <TD STYLE="border-bottom: Black 1.5pt solid; width: 83%">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 40%"><I>Signature of
Authorized Signatory of Investing Entity</I>:</TD>
  <TD STYLE="border-bottom: Black 1.5pt solid; width: 60%">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 30%">Name of Authorized Signatory: </TD>
  <TD STYLE="border-bottom: Black 1.5pt solid; width: 70%">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 25%">Title of Authorized Signatory: </TD>
  <TD STYLE="border-bottom: Black 1.5pt solid; width: 75%">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 5%">Date:</TD>
  <TD STYLE="border-bottom: Black 1.5pt solid; width: 95%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: right">EXHIBIT B</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.5in"><I>(To assign the foregoing Warrant,
execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0in">FOR VALUE RECEIVED, the foregoing Warrant
and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%">Name:</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 49%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Address:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Phone Number:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Email Address:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">Dated: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> , <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">Holder&rsquo;s Signature: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">Holder&rsquo;s Address: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">&nbsp;</P>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>ea025575801ex10-3_actelis.htm
<DESCRIPTION>FORM OF PLACEMENT AGENT WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><B>Exhibit 10.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">NEITHER THIS SECURITY NOR THE
SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION
OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.95pt 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PLACEMENT AGENT COMMON
STOCK PURCHASE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">WARRANT ACTELIS NETWORKS, INC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 136.85pt 0pt 191.25pt; text-indent: -40.8pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 136.85pt 0pt 191.25pt; text-indent: -40.8pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 55%">Warrant Shares: [____]</TD>
  <TD STYLE="text-align: right; width: 45%">Issue Date:
[_____], 2025</TD></TR>
</TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 136.85pt 0pt 191.25pt; text-indent: -40.8pt">&nbsp;<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt auto; text-align: justify; text-indent: 1in">THIS PLACEMENT
AGENT COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, [_________], or its assigns
(the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the Stockholder Approval Date (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00
p.m. (New York City time) on the five (5) year anniversary of the Initial Exercise Date, provided that, if such date is not a Trading
Day, the date that is the immediately following Trading Day (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe
for and purchase from Actelis Networks, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to [_________] shares (as
subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock
under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.9pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><U>Section
1</U>. <U>Definitions</U>. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated
in this Section 1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.8pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board of Directors</U>&rdquo; means the board of
directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any
other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so
long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally are
open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo; means the United
States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.9pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.75pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.85pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.9pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Stockholder
Approval</U>&rdquo; means such approval as may be required by the applicable rules and regulations of the Nasdaq Capital Market (or any
successor entity) from the stockholders of the Company with respect to issuance of all of the Warrants and the Warrant Shares upon the
exercise thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.9pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Stockholder
Approval Date</U>&rdquo; means the date on which Stockholder Approval is received and deemed effective under Delaware law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed
or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market. &ldquo;<U>Trading Market</U>&rdquo; means any of
the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE
American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or
any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means VStock Transfer, LLC, the current transfer agent of the Company, with a mailing address of 18 Lafayette Place,
Woodmere, NY 11598, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.65pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt auto; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Common Stock purchase warrants issued by the Company to Rodman &amp; Renshaw LLC, or its designees, and H.C.
Wainwright &amp; Co.. LLC, or its designees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within
the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section
2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares
specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless
exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise
shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required.
Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company
until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case,
the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable following the date on which
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise
within one (1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and
agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number
of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.9pt 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$0.4625</B>, subject to adjustment hereunder (the
&ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part,
at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares
equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="white-space: nowrap; width: 0.25in; text-align: left">(A)&nbsp;=&nbsp;</TD>
    <TD STYLE="text-align: justify"> as applicable: (i) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section
2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior
to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities
laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of
the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P.
(&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of
Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including
until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii)
the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of
Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such
Trading Day;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="white-space: nowrap; width: 0.25in; text-align: left">(B)&nbsp;=&nbsp;</TD>
    <TD STYLE="text-align: justify"> the Exercise Price of this Warrant, as adjusted hereunder;
and</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 0.25in; text-align: left">(X)&nbsp;=&nbsp;</TD>
    <TD STYLE="text-align: justify">the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless exercise.</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.75pt 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><U>&ldquo;Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and
expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding
date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from
9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume
weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the
Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The
Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price
per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined
by an independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and
reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.85pt 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act,
the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to
take any position contrary to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.85pt 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.95in"></TD><TD STYLE="width: 0.45in">d)</TD><TD><U>Mechanics of Exercise</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.8pt 0pt 2in; text-align: justify; text-indent: 29.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.4in; text-align: justify; text-indent: 0.25in">i.&nbsp;<U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the
Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The
Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a
participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares
to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or
manner-of-sale limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of
a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant
Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by
the date that is the earlier of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and (ii) the
number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such
date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for
all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been
exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other
than in the case of a cashless exercise) is received by the Warrant Share Delivery Date. If the Company fails for any reason to
deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay
to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise
(based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per
Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery
Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that
is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard
Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s
primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.4in; text-align: justify; text-indent: 0.25in">ii.&nbsp;<U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.4in; text-align: justify; text-indent: 0.25in">iii.&nbsp;<U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1.25in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.4in; text-align: justify; text-indent: 0.25in">iv.&nbsp;<U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its
broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common
Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise
(a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained
by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise
at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the
Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in
which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been
issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common
Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with
an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the
Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable
to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit
a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree
of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock
upon exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.4in; text-align: justify; text-indent: 0.25in">v.&nbsp;<U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.4in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.4in; text-align: justify; text-indent: 0.25in">vi.&nbsp;<U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.85pt 0pt 2in; text-align: justify; text-indent: 20.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.4in; text-align: justify; text-indent: 0.25in">vii.&nbsp;<U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.85pt 0pt 2in; text-align: justify; text-indent: 20.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.85pt 0pt 2in; text-align: justify; text-indent: 20.25pt"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.85pt 0pt 2in; text-align: justify; text-indent: 20.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other
securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the
number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with
the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company
or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the
Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.
In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of
securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such
number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% of
the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon
exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions
of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of Common Stock
outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder
and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective
until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented
in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof)
which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements
necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor
holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.85pt 0pt 2in; text-align: justify; text-indent: 20.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.45in">a)&nbsp;<U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective
date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.45in">b)&nbsp;<U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are
to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the extent that the Holder&rsquo;s
right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.45in">c)&nbsp;<U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the
record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>,
that to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership
of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance
for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.7pt 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.7pt 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.7pt 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.45in">d)&nbsp;<U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in
one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the
Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares
for other securities, cash or property and has been accepted by the holders of more than 50% of the outstanding Common Stock or more
than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions
effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which
the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires more than 50% of the outstanding shares of Common Stock or more than 50% of the voting power of the
common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant,
the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior
to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the
exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is
the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result
of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the average amount of Alternate Consideration issuable per shareholder in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the
relative value of any different components of the Alternate Consideration. Notwithstanding anything to the contrary, in the event of
a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable at
any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the public
announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash
equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation
of such Fundamental Transaction; provided, however, that, if the Fundamental Transaction is not within the Company&rsquo;s control, including
not approved by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive from the Company or any Successor
Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of
this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction,
whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given
the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; provided, further,
that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders
of Common Stock will be deemed to have received common stock of the Successor Entity (which Entity may be the Company following such
Fundamental Transaction) in such Fundamental Transaction. &ldquo;Black Scholes Value&rdquo; means the value of this Warrant based on
the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the day of consummation
of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S.
Treasury rate for a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction
and the Termination Date, (B) an expected volatility equal to the volatility for the remaining exercised period as obtained from the
HVT function on Bloomberg (determined utilizing a 252 day annualization factor) as of the Trading Day immediately following the consummation
of the applicable contemplated Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the VWAP
for the 30 days prior to the Trading Day immediately preceding the consummation of the applicable contemplated Fundamental Transaction
and (D) a remaining option time equal to the time between the date of the public announcement of the applicable contemplated Fundamental
Transaction and the Termination Date and (E) cost of borrow for the company&rsquo;s stock at the exercise date. The payment of the Black
Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within the later of (i) five
Business Days of the Holder&rsquo;s election and (ii) the date of consummation of the Fundamental Transaction. The Company shall cause
any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;)
to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions of this Section 3(d)
pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable
delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant
a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which
is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the
shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of
this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares
of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and
the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting
the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory
in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to
the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
each and every provision of this Warrant referring to the &ldquo;Company&rdquo; shall refer instead to each of the Company and the Successor
Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally with the
Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall assume
all of the obligations of the Company prior thereto under this Warrant with the same effect as if the Company and such Successor Entity
or Successor Entities, jointly and severally, had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled
to the benefits of the provisions of this Section 3(d) regardless of (i) whether the Company has sufficient authorized shares of Common
Stock for the issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.7pt 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.7pt 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.45in">e)&nbsp;<U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.95in"></TD><TD STYLE="width: 0.45in">f)</TD><TD><U>Notice to Holder</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.9pt 0pt 2in; text-align: justify; text-indent: 29.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.4in; text-align: justify; text-indent: 0.25in">i.&nbsp;<U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.9pt 0pt 2in; text-align: justify; text-indent: 29.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.4in; text-align: justify; text-indent: 0.25in">ii.&nbsp;<U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the
Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares
of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection
with any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a
party, any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is
converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution,
liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the
Holder at its last email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the
applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the
purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the
holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be
determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to
become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to
exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or
in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent
that any notice provided in this Warrant constitutes, or contains, material, non- public information regarding the Company or any of
the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.
The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective
date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.45in">a)&nbsp;<U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof, this Warrant and all rights
hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant
at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the
form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon
the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or
Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant
shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant
to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this
Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant
Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.45in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.45in">b)&nbsp;<U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be identical with
this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.9pt 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.45in">c)&nbsp;<U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.45in">d)&nbsp;<U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, provides to the Company an opinion of counsel, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that the transfer of this Warrant does not require registration under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.45in">e)&nbsp;<U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.45in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.95in; text-align: justify; text-indent: 0.45in">a)&nbsp;<U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.95pt 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.95in; text-align: justify; text-indent: 0.45in">b)&nbsp;<U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.95in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.95in; text-align: justify; text-indent: 0.45in">c)&nbsp;<U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.45in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.95in"></TD><TD STYLE="width: 0.45in">d)</TD><TD><U>Authorized Shares</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.75pt 0pt 1.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.95in; text-align: justify; text-indent: 0.75in">The Company
covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient
number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company
further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing
the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.7pt 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.95in; text-align: justify; text-indent: 0.75in">Except and
to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its
certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities
or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.9pt 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.95in; text-align: justify; text-indent: 0.75in">Before taking
any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise
Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public
regulatory body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.4in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in">e)&nbsp;<U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and
construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of
law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders,
partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough
of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.
Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in
such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo; fees and other costs and
expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.4in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in">f)&nbsp;<U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.85pt 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in">g)&nbsp;<U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder
in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.7pt 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.7pt 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.7pt 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in">h)&nbsp;<U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice
of Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service, addressed
to the Company, at [_______________], Attention: Tuvia Barlev, email address: tuvia.barlev@actelis.com, or such other email address or
address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other communications or deliveries
to be provided by the Company hereunder shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight
courier service addressed to each Holder at the e-mail address or address of such Holder appearing on the books of the Company. Any notice
or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if
such notice or communication is delivered via e-mail at the e-mail address set forth in this Section prior to 5:30 p.m. (New York City
time) on any date, (ii) the next Trading Day after the time of transmission, if such notice or communication is delivered via e-mail at
the e-mail address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading
Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv)
upon actual receipt by the party to whom such notice is required to be given. To the extent that any notice provided hereunder constitutes,
or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice
with the Commission pursuant to a Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.95in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in">i)&nbsp;<U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.95in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in">j)&nbsp;<U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.95in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in">k)&nbsp;<U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.95in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in">l)&nbsp;<U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder of this Warrant, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 71.8pt 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in">m)&nbsp;<U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.95in; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.75in">n)&nbsp;<U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 36.1pt 0pt 0.1pt; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 68.45pt 0pt 0.5in; text-indent: 71.95pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><B>ACTELIS NETWORKS, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: -0.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: -0.75pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; padding-right: -0.75pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 36.1pt 0pt 0.3pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">NOTICE OF EXERCISE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">TO: <B>ACTELIS NETWORKS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">(1) The undersigned
hereby elects to purchase _______Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and
tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0.5in; text-align: justify">(2)
Payment shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-indent: 0in; text-align: justify">&#9744; in lawful money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-indent: 0in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#9744; if permitted the cancellation
of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant
with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: 1in; text-align: left; margin-right: auto; width: 25%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">The Warrant Shares shall be delivered to the following DWAC
Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: 1in; text-align: left; margin-right: auto; width: 25%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: 1in; text-align: left; margin-right: auto; width: 25%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: 1in; text-align: left; margin-right: auto; width: 25%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.5in">(4) <U>Accredited
Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act
of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">[SIGNATURE OF HOLDER]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 17%">Name of Investing Entity: </TD>
  <TD STYLE="border-bottom: Black 1.5pt solid; width: 83%">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 40%"><I>Signature of
Authorized Signatory of Investing Entity</I>:</TD>
  <TD STYLE="border-bottom: Black 1.5pt solid; width: 60%">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 30%">Name of Authorized Signatory: </TD>
  <TD STYLE="border-bottom: Black 1.5pt solid; width: 70%">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 25%">Title of Authorized Signatory: </TD>
  <TD STYLE="border-bottom: Black 1.5pt solid; width: 75%">&nbsp;</TD></TR>
</TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 5%">Date:</TD>
  <TD STYLE="border-bottom: Black 1.5pt solid; width: 95%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: right">EXHIBIT B</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.5in"><I>(To assign the foregoing Warrant,
execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0in">FOR VALUE RECEIVED, the foregoing Warrant
and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%">Name:</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 49%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Address:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Phone Number:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Email Address:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">Dated: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> , <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">Holder&rsquo;s Signature: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">Holder&rsquo;s Address: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>asns-20250902.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 86o5s7xRiXhun8uDb31cWaSIiaPty5BxSZkxsmx3HfkqHyIsV3DhZSu4BY9GMecO -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:ASNS="http://actelis.com/20250902" elementFormDefault="qualified" targetNamespace="http://actelis.com/20250902">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://actelis.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="asns-20250902_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="asns-20250902_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>asns-20250902_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>asns-20250902_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="asns-20250902.xsd#Cover" roleURI="http://actelis.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://actelis.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Sep. 02, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep.  02,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Actelis Networks, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001141284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-2160309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4039 Clipper Court<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Fremont<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(510)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">545-1045<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ASNS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea0255758-8k_actelis.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://actelis.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>asns-20250902.xsd</File>
    <File>asns-20250902_lab.xml</File>
    <File>asns-20250902_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0255758-8k_actelis.htm">ea0255758-8k_actelis.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0255758-8k_actelis.htm": {
   "nsprefix": "ASNS",
   "nsuri": "http://actelis.com/20250902",
   "dts": {
    "schema": {
     "local": [
      "asns-20250902.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "asns-20250902_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "asns-20250902_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ea0255758-8k_actelis.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://actelis.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-02",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0255758-8k_actelis.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-09-02",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0255758-8k_actelis.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://actelis.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001213900-25-084029-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-084029-xbrl.zip
M4$L#!!0    ( +B (UNR<E >)@,  -\+   1    87-N<RTR,#(U,#DP,BYX
M<V2U5MMRVC 0?>],_T'UN[$=0AH()).$2<H,N4S<I&E>.L*608,L.9(<S-]7
M\HV+P07:\B3OGG-VU[LKT[U(0@(^$!>8T9[A-&P#(.HQ']-QSWAVS4OW>C P
MP,7YYT] _;I?3!/<8$3\#N@SSQS0@)V!>QBB#KA%%'$H&3\#+Y#$VL)N,$$<
M7+,P(D@BY<@B=<!)PQD!T]Q!]@51G_'GIT$I.Y$R$AW+FLUF#<H^X(SQJ6AX
M+-Q-T)50QJ)4LQ,[_^U&O\/"*\FG)ZPEOB9/^'42T].X/VHZW@_H#C!\E//6
M5>*^31,1)LUOP?3]VWP@7IK]R9L;'U_];-_>(>\A"]D5W@2%$*A>4-$S='UY
M>;-F@_&Q=63;CO5Z-W13G)$!.PG!=+H)[K3;;2OU%M *,AEQ4D@W+>T>08%*
M9>7%-7A,A8346\'[LB0L@UM6YER!XHW0DPR*"ZB/UG ">8TQ^["40^&/6@4P
M%N88PJ@$!U",4M'<L0(67%:!RK@.,N4\0F(C-'.M$"[=>[?$0D\B@M.13$%V
MVSY2>T50B*B\83SLHP#&1.7Q'D." XQ\ TC(QTCJ&1,1]%"]6#&GD%*FQEFM
M5&[1MBC":EY+@S+I_G8X(^B[2ASH@]JGC1&TS[IFZD8P /9[1G9<TBK4?!1@
MBM/(^?HXP-3+$NLBU3%E=JUU<%4I%LA_H.?I.>)(*'I:T5 9<GX.J>=ZD'@Q
M.8BZR*^.F=N+]UAYP<46/:$ I-O7T7/2,P36UY^1VR8<!3T#"BK,HIV_5-D-
M-4<%1$>HV;ZT1^MO*@]<2$#N550JMX,281'B$JMA7KH"LM2QU/3'I3! QQ$&
ML/YAY02.]JU<41#YCR4/M7ZUUJZUNECJ>7WYNJI<QB6@E26NNT*SRW_(O%2J
MAJ*?S()G:I/I')E-IY$(?Y'I/DDLWL!^212\ Y+8<I%OBB^VP?4A':%=@V[Y
M(-0&W<BQ$)&BL!R<PO+GXR]R2&7V2F*EG;[DEI;0HL>F[:@F;D_G3\ST61PT
M!!Z+J>3S?09AF5(\'-:-Q8=_MT84^*P)^K_ H6$/F()J\$TCT+4R-77\#5!+
M P04    " "X@"-;?*-.P/T*  !_A@  %0   &%S;G,M,C R-3 Y,#)?;&%B
M+GAM;,V=76_CN!6&[POT/[#N30N,XW&"72#9R2XRGF1A;#9)8\]LVT6QH"7&
M$4*3 24G]K\O*8FR1/%(2HJ2G(L9C_@>ZJ7XF*2^CC_]M-M0]$)$FG!V/IH>
M?1PAPB(>)VQ]/OJZ&%\L9O/Y"*499C&FG)'S$>.CGW[\\Y^0_//I+^,QNDH(
MC<_0%QZ-Y^R!_X!N\(:<H9\)(P)G7/R OF&Z55OX54*)0#.^>:8D([*@V/$9
M^OYHND+C\8!JOQ$6<_'U?EY5^YAES^G99/+Z^GK$^ M^Y>(I/8KX9EB%BPQG
MV[2J[>/N8_FG"/]$$_9TIOY:X90@>;A8>K9+D_.1VF^YV]>3(R[6D^./'Z>3
M?_YZO8@>R0:/$Z8.6T1&.DK58HN;GIZ>3O)2+6TI=RM!]3Y.)MI.5;,L33KT
M-2=I<I;F]JYYA+.\UWMW@T"%^M]8R\9JTWAZ/#Z9'NW2>*0/?GX$!:?DGCR@
MO)EGV?Y9DI0F"H11N>U1D >[&2K$1,5/&%GCC,1J1Z=J1]/OU8[^6FZ^QBM"
M1T@I)1]@NTX;=95!$]=F[XA(>'S)WN?:C/9D7WYW1/8_-* >[[P)2YYA^B[S
M]4CGMF_(^X[X(<[]D9;#/'G?D:Y%_E]L9VW+;SZ\]N-*U<9K^:EAD>PR.8&1
M6)M4572,P/D>\HFAK+NJG4>->JD:S;EHMUW-C'F=*8F.UOQE$I-$UGW\G?HP
M5A_R9LO__#'C<B%PL4HS@:-,UY0WXWQD*9^8EI3R0FA?6$0]C2L5DXC+J>DY
M&]/B,!;A#X)OK+LM6\TMA7_0515?'!:Y"\!H0R9(RK<B(F_JE;I;Z"B5CC94
M*M2*BK#QU\7HQUR#?M>J_WR:'&IQT-%R";3=$)8M98V6%C2+776SS93NY7I9
M$)UL,63VL98@I7'<P1=RQ[':^17%:XM]H]Q5%UMMZ3YN% ;1R39'9B]7&J1$
MOKKY"TDCD3RKY7Q7.QHRYYUN,=GJ^YHF+ 3:QF 2:EI/ _L]62=J:E$6U/DM
M41L[AC% [WKH[[1MS@56<1#0#'$(SA;U(%1%>>+H@K$MIO?DF8LN?)HRU]38
M3)JPU#5!,6(Q!J)1:%$A]D3$/[;RC)T(NN^%HJ5TS05@U43#D 5%A]T;"$@E
M]\O(4F"6)FH ZX6D+75^N@&8;9UZ&+J@. ',P:<DE=XO*8M'0JFZ'8!9_X!B
M$[NF!39L\M)6!D4,: ]D)H] 94@XV%R^J-6Y7"8-;&Q-[Q.>ENTN?BIQL B9
M#@=2E(<A%>>)I-IMB!Z&6DK7] !636X,65#$V+V!K!1RE.O]0W+)XD&(5#H_
M@!@V[7B4H@#A:#KK0T.J?8)QE:01IH67*[DM[6B>1>L:$-"N"4E+&!0HD#L0
MEB) ,Y.'> 7F7P2+8;C4E'Y@:5FUHU+) @3%]-:'B=)[@62V%:+A&IYQ8*FS
MF[(]9JO[LX N"%!ZS+7NVA;R!BB>9J!+EB797CU.=[/=K(BP-*XM<<4&9$XS
M898'P0)@RF2@D"&E0X702\_KNP0L4P\Q@LTQ96X)L)ML4M#4!$2"U1A PT&;
M/U/JA8B9')D$IG,6D]TO9 ^VJZ5SRP1@LPF%(0J("KLS (M2C'(UDG(O8-R)
M9(/%?I%$/5-%6^@6#<AHDPU3%1 <@#6 CE*-%O.9SYEDB7?S6(*:/"3%\^ ]
ME(!ZM[#TV&XR X@#0J?;(4"0#$+-*)\@S5G$Q3.O/>XPXULY .YG/(97*#U1
M;J$:U(0F6ITA 0$VQ"> 62/T0_%,"N+J-9Z\ J1J\$+<11S+ Y66_UPGC$S!
M]ENU;NGJL-MDRB(,B"38'<!/J?R@/R 5@VY9*- <OZ&IQ_ZA.1X*S7'0T!R_
M!YKE*P\$FI,W-/7$/S0G0Z$Y"1J:DW=!(SO>ZU@SDQ]OQ9*_VA[.!I5>D&E;
MM0)SD(6'2\M;'RPJ0*UG5(A/3/*%U:VX$_PE81&\9(;D7H !3%NI,;3AH6,W
MV,=/M2#6<5['FF)1WOLET3(_HTS3I'V(*33A0=(TUCNX%&J?2-SQ-,/TW\ES
MYXFX7>P%#ZMA*R0-97BHV.SU 5/$(!GDX\2ZQ%7=T+"^2F:4NWL%V&+K\ IP
MK3 ("&R.VJ\ %U=/"I'K;E:,"H*!$:%9[*R3+::J/JZ5A='%;4.M'LZ_UU+C
MXXNLLKO0NT?.X <$VA)7/0V9T[UME@?1XX IL]=S&<IUGJ[&JPP3J7WXKI4Y
MF]E-.]5$K@N"Z%W336N:UN6.>_,WD61RSS.^V6Q9>9?']MP@H'/5RYTV=8];
M14'T?I<SDX12BYIBQU@L.$VB)$O8^E=Y\BD2;&N53>0*"-B@IJ&M" (%T);)
MP4&(M-(Q!'>"* B)[(C\)4"56$C</CQ89_LNL2LH^@UK.&!E$)#TVC-AD0'C
MJ!:!BA"4Q_C%9IZF6R+>!(\EQ!-"H'D I)8^1)P@D[U0%8$^V5J0:"OGQ_WT
M>+5,,FH[N6Q+G,U)@+EJ1C+*@V #,&6RD)<A_H"FQW];_1WI*,?=?\.7 JO<
ML8O]9L4ID'W*JG(%08=%S8%%$@0*L"^3AAN.2BDJM#ZR4S7,6IICE+L"P&I+
M=WVC,(A.MSEJ??D;?>UIR+_<18_2% %>2+#+7 _]-I/F\%_7!(% A['624DI
M15KKXX6$PY2U[E\$K+TM M8]BX!UB(N ]=!%P-K;(D#OMD@1(L>EVQ5-UAA(
M3MBI=@U%AV63#XLT*%1@?^"8486@0XSKC)9YBC.5GE]L\OU?R0^65@(Z9SDM
MNVQ622UMHB 8Z7+62FM9))VKB9%2N^9B&R<9B0LS5PG#+$HPK=(CVJZ(]X<X
MHV6@^0J<'GT8# TSV<*I"-.Y#*O 0ZI+UY?2BP<P?B.4_L+X*UL0G')&XN):
MBNU.4;?>[1,S/;:;#\T XB!P&N(0>'1&!8V?5!328>65,"\D?>-TRS(L\G?)
MA6UD G1NR0%L-HDQ1 &18G<&$%*)4:'V\X)VD3VB6F05OSL$-A"2.WY=N].T
M\=:V51L0,YT&H7>XRYP?A[5Q$>7I%<N,J-^+2%[(%YSATAO87DCN^J7*+M/F
MVY0V;4 (=1H$WY^L8E2J&*R9\I8R1LSD4FO-.YX2-U3N$\>T++9SQU22@/"P
M^>K((".0UGIA8;'!E'[>I@DC*3P1&2JW+%@M-EEH2 )BP>8+8"&7(JWUPL+E
MAHBUG-Y^%OPU>RSSLX)M ]1NV>BTW&3$*@V(E2Y_ #,Z!!4Q.J6N'WAVAX3B
M199%N*46J6-L0+,&,RU=2,! YEJT4!*IZRTW/$-+CKZF!&6/!%V6/T-7SP1?
MU./KET:B2+T04:S*68R%#:$NL?-?'0$-MWY[I*4, J1>>_#OD%012(<XIN96
M,BSJYW&YB7E&-N#;#OTAK@@::EYSU*</@J:!)DVF\K#FR74>B%2DSVQ&]>3V
M\!*O(7*\,K88-!;&-440C("VH&5Q_;<"_.3.VZYH$EU1CN&K+ V-XXQY;7M&
MLKR#(" "VJZ@%'FY$.5*+_W_&;,GL7W.HOV=X!$AZBFKM!JM^JZ_#8QVR\R;
MFM2D:5!H0)R]Q2] X*$*5*OC0VW&\GDQ3STTKK*Y\>AI\8CE ;S=9JF:0:4Q
M^"IX9Y#CVPL#&F#<9.B(" B] 3:A&PYY),I#/Z B&-6B/9V?I8<L@"3^O+\G
M#T2H]PZ69)=]ECMZZCC#&!#K^NQM<'/,D[G>P" @?*M;Z%0O1?4*T$H](U96
M@7Y7E:"\%MOOE]<W7<M/<K/>)/]:X93(+?\%4$L#!!0    ( +B (UO/N=L2
M5P<  -)7   5    87-N<RTR,#(U,#DP,E]P<F4N>&ULS9Q-<]LV$(;OG>E_
M8-6S+$MNTUJQF[$5*Z.)$[N6D[2]9" 2DC & 0T 6M*_+T"*BCX(<'WAV@=;
MIA; OL^"()< >/%NE?+HF2K-I+AL=4].6Q$5L4R8F%VVOHS;5^/!:-2*M"$B
M(5P*>MD2LO7NKY]_BNS/Q2_M=C1DE"?]Z+V,VR,QE6^CSR2E_>@#%501(]7;
MZ"OAF3LBAXQ3%0UDNN#44/M%T7 _>G/2G43M-J#:KU0D4GUY&&VKG1NST/U.
M9[E<G@CY3)92/>F36*:P"L>&F$QO:SM=G6Y^BN(7G(FGOOLU(9I&%I?0_95F
MERW7[J;9Y=F)5+-.[_2TV_GGT^TXGM.4M)EPV&+:*DNY6JK*=<_/SSOYMZ7I
MD>5JHGC9QEFG=&=;L_V6!>QW/-&LKW/W;F5,3![UVF8BKX7[KUV:M=VA=K?7
M/NN>K'32*N'G!)7D](%.HUQFWZP7MB=IYCI":W-LKNCTLD6TT+:BWN^GYZ<]
M5\VO VG[9RMR%=BP;]TEL:&<Y8'NN.\Z&[O.7K,+1345)E=Z:P_LM4]7QO8F
MFI0>N&IJZ]]4P(RSW725;M1V_2I+;5/V8V&Y\:/TA,MXKW'N^$NUK[[LRSEE
M3>.3F7SN))1U'!'W(4>38['_?,\;NIIHHZRW94V<3"C/Z_]N;0Y,.@UX59)X
MM#56.[5O<>C3;LRN5!Q)E5!E69=U$17O1>JX6VXL.@NB;$7M>,[X-LA3)5,?
MG0T)Z7%T%Y1MHAF:5[;]Q/DPY&16C?/ !,BSBP&T4@T6T?=4QXHM')<:L'N6
M0+X]5+X5VAK&7)X[#W3&G+_.%7>QI>Y@>%SP% &"/\,<*8)JD2)P)41&^ -=
M2%4#?M\2R/LW3-Y5VI P_YT19:CB:PCI(V,@[-\Q87L4(O%^5$1HYOA @!];
M XF_0;WQ\&A$0CZ>4\Y=_D8$J)=7V0.Q_X&)W:_S%8"_>7;7=WMI@;/?*0+$
M_^=KP7^D%BD"]U0QF=A+N@*P/S(&4C_'I.Y1B,K[1B10VEM3</Z##_M 'A+J
M(=,QX85'0WM,AW%7F$.1H^2<M3)1L?]+B0)#WS&&(D=)0VLD-@Q\D"FUYTQP
M5/%;0Y&C)*!U(AMF?B,,,VOWP/]SEDY^/#C=9WUL!66,DG3Z1*&P+9\T".,F
M,D)\#RVAC%%RS9 X%,X#JT<1/A()77VDZQ#H(U,H:90<,R@/!?6]8BE1ZS&+
MZP>-8ULH;)3,,BP0A?8C68T2JXI-63$56 _=6P3*'B6M!,E%"<%(Q%(MY,[C
MXH',[/FX'L@D.*37%(2& R7??(%TE*!<)8G%I3=_;IF@W5 H*LW!<T1X 0C(
M?"78>R_#WH-C1\E#:V6^$NQG+\-^!L>.DHO6RL3$/K ?[]2C7'IFH+W&4.0H
MN6B-1$S@^97F3MTK^<R*%5%UU(]*0-$CIJAAL:@=OKC(0WI[:0GEC9BN5HO#
MY'POM2'\/[:HNY.LMH<R1TQ<0T*;?L!8Q-T]M/ M)3HP@?)%R54KY32-U$58
M4>+OOOL64* H"6B5F(9YWDHW]S&7(O@\]M@*RA4ED_2):GK@=>N(M??4W_D:
MO((-95@]E-$PQF^*&>O!0*9I)C;/:#RS8AY3*%Z4]"\HKV'48\E9S P3LT_V
M#E$QPJLY5]E!(:,D>WYA#1.^5]1%FMK;[GP=E]MHH.ZF4]_(&[*'$D?)]>J%
MXI(?:9U1]5+^%:6@44!)^Z"BFQYG:)S986_=[4T>W8X9SRAS9 5EC9+R^40U
MS/:S?%3$;=0;K].)Y/[M(96&4,(H"5Y 6L.0]_RHQGM@ @6+DME5RD$:$VY6
M\9R(&?6O7JBVA )&R?1"XM#&WAEH[)V]<.Q%R?A\HI#8%FO#[1EU-^%L1OP[
MR8(%P/ML,(D'I#:]?R_?\N/V<*LT]V-H/U1C]YA"@>-LD0S):QIUEC!#D\*E
M(1-$Q#:EVNYK\V3G]:6@ <#90PD4C?)X_QOE_*.02S&F1$M!D^)6/_2$WUL$
M&@7$.<0:N2@A^"IY9BFI?"&H\IP#'E,H<L2Y0X\\G+67Q:+F[;6G>%E'B+BO
M!!0\XB1B6"S2^C1#G<_LF;XGAFP\#/'WE8#R1YQ0#(M%6S^O!O;",Y/A.?,#
M0RAMQ*6PE=)0((]3POEUIIF@.CBV'!A"(2.N>:V4A@+Y)J5J9@>U#THNS7RS
MMS,$VU, "AUQ96M0*@[\U8]]Y,7^MR#Y"FOPVPD0L7M%8KUV(X[=0HKB2BX2
MHCS40_90[J@;*_U"&R9_9^94[=X_Y<Z,;-X66O107PH:!91T%2H:Y]JZLY,_
M>&G=LX/R1DQ,JX3A[)G*)IS%0RY)\+Y\SPS*%S$+K9"%@O>:B">5+4R\OE<R
MIM1-G^CMV09(B( 50$."F)^^" 7.XP*9IFXSD8R?QG,K6M]E)G]UJ?4O^- @
M6 X:&LQ-G #A2'=!^L=&+YI<KQ_HE"JW3.&1KLRU;>@I?%,$* Z-#^H;A< 8
M*L)TT3G2=6L/N+?3%M^X7^X-K/;(_U!+ P04    " "X@"-;_HR),KDC  "[
MP0  &    &5A,#(U-3<U."TX:U]A8W1E;&ES+FAT;>T]:5?;2K+?]2OZ>>;.
MP#FV\0H8$N8X!A)N"'"Q,UF^<-I2VU:0)4>2L7U__:NJ[M9B2V9)(,MPSTP
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M0=%0>I0"^EQK+"V_ U+Z::&;6\BK$]]:-]U:<:L2+LI[S$^6/Z@D(U4A'&L
M3&C?<-N1-B&]!+WCV&**\XSY-1Y@4&;3*#+:J%9Q9E.=;")CA)E2(2L;EHS#
M#+.,K$HUW/(AR'1\(6D\&&@\D)$# P!VN<42AXXSK3^;3+8,@W:S&)VXR#($
M4DH_H9>YKD/ ,Y^<PM13AZ\F;E(!I^]\O\U/QSH@6M0UCH:^._!9KB0<,E\8
MQ(!,!'CNRPY&\K(Q2]8"(<8B%VA)OJB8FV8ERQ.!\C,FL@"7SD[?B.7A@#HM
M<0-.S"0=\H@&D!^040%*,&#A%P L7(W#>JJ8(18L\7VR^H!">O(R^Z!+FY;>
M2)YS[*]3VP*_W<B*^\;^:HBE,P :Y4J%]3N;H/=EMTN* 1MTJ#L1*WKFNQB@
M(^GX XIBA17Y2!E2&JD9E/"-[8=3D?:@(Y<RY97>XSH@(^'^+^47@IBGH\/C
M.L)/H<8;VQ%#.0]?.N^P_@JBN% #^??&HWLQY- Z89,$*S9S,F(5&0F45:95
MV%T.7F3ZJT9ZL?(8+=XS;4_0!H#]2>4R*%*@<R/0TJ83F'??@6?9$<N.8WB*
MIF/(G>1QC>!9>"2= 4,%4<@76$U.^JDX6NJ84)$IJ].RP30-08&1U:G_HO J
M'G>!IQ3,\X4RH)/%6/J C9'8+7;+X9HDA'B@+4_@1!H6+]UT1-*(SJW?6HJ"
MJ8JJJ6F".XEF@*]*L&50,?IV-)D(@S1V5@\ORK'\&QD]2W27!A %F-5A?*#9
M])5-$G!Y8C @?RR8.I%7D8>]_H(MB>2\B&!JW6BDR8J4<#G,CA213&,E@X.I
MA%$.2&76EB7Q#O@:+@]I,RC4K$[8ZOX9ES!0^41^#?ARJIGGP5!,26U5TH<1
M6QUAQC+ZB6R97*MD%5D'![MCRF(<6#C"3UEG=="Q7DD<1).SX6YB45(R;IU+
M\QCK!O)!?E'==4909M+ MC8!&2YPM,*%]B[CZNI!8O $RP'#F%R?P]>TF;R-
M"Y]/W>C>EV1P/V];8.'YNX+4&D%57 FARRQ)(M6BTYU (E&4G/SRJ.(#6\D(
M8]=$;S>0L4DC0U1D0!OE!\#J5EG(G.42Y\P2_L'R1BSO*7;($V12,S]K'%#,
M'SA5M! WMS&V0P<'GM7RFN0F!H0PZN19LA /]9"*BNGT^OJBQAFG"[:B([8K
M5_\I!WS)')[)STV2+I*WR#YO4%QMJG)4&<7C*Q5>N9?\T+5P8<C-4:KL,\"Z
MSVI15G_B /!+?>D6"G1/C(SZS53R;/5N%[W5*VH]#I=$8<Y4$2RV65?UFE\+
MJERI55@PL@I"&)P8V :/2G:C4W2ZF$M)8'W1A^F!?D_>C:B5F*R2GV$].D5G
M/==9+%>?!)%<C^ZZE*-R^0:0B\=+2,KCU#A8 "HF,9(L<X\T+GES(HA6'(]+
M\DTQ;J).+JZ(CXIR***K5H,8\=4]@6KL[\5UW_\"<G47=;U<J;'W;N(07)<[
M$M='8"R'BT1T__DBZB4Q8KOR0P+1@286W^_M#6XM^\9D@J^/J<  B4U(A#*E
ME.A3UES6A-^E5/RWW28B79!]9/UUP)(7\E? *D@;BYUZWK4L3]/7&#TVU?ZX
M?&DOG\ ,)+!(1"?N=)*^8>*,X4 ASE&(2[;5U]: 6!;<35Q0=N&#0QNF4G^G
M\$-]P/U2T-F(MAD:E QL-1/WQZV<F^W1_6%KP*#C37'U5)8-I/2.U(%8"28<
M6PPH)B?3$$HC&?UI>-M4J$N'4XZ*2Y5=TI5J3.L$?"^?H%ZYX> Y3P-U!T^0
MC&D&WECHYPKO\J36PG.MG)NB08-X3AFW4(H/V;V(#A5B'S$(<RR\*?C_5'"%
MT$S00D$)-*50C4T%.;FX6EI^XL*O,I,1:48GXM5Q=1 KL$_I6V9(V(7\FJ+"
MS .?=AB=195?G*%SZA/RN-3A\3R48ZC)I\.@V)?.R25N3L(+:FS?G(XQCF6J
MP"WN J ]2-[ %#MW*SSQY ?2TA)A;75.X[DZ)U6=4__?J\YY,JU)QDD+C!.0
M+]'5QO%%5O* DS+Z?P>E63C8L#:32WJRY?S47]K-_,;V[1]\59.W;OVVJS[]
M>.:5UWT/4V$B9DB<+%[CMWZ?5H-;N17>P]@-?Z3/S-X" (8+LC"5A8#;O@'*
MV<C'+YX)7JDUFSO-W4I5S*N54O6*RV_DE$?AN'!PK,ZNKKCU+[;X=_K8KO((
MUB[FEF=/N@6UQ]Z"6O86)&(Y_[O(KS\V\NO9R,^)[?W/;D3C.^U#QP,0R:P#
M$0-B156 '>()4+I(> .OI;8L%=>.KEYT;%>PCZ\N3YGE@=$/6[+YN!_Y?7KC
M)/J8\^W.0?/9.4@Y!XUGY^!Q2+%_T#UY?=;NO;\\ZCY^D'?)86ZL>,Q/Z:E?
M+%VHG[P0S8@2YVN_=EU4'5,?\J7#AI2NMW0DA^)S,CE#'X^A C&;OA8QXLY
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MY'#8&'UP,,)AV>< ZQ^\'<)KAZJ'[\GF_=>MOP'V "K/X.#@W2G&81W_'M0
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M?:7_]8CT]O5ULQYIW7YT:-8^.K0_JH-WN/23?SS:,>N\XQI69X"0 /^$2MB
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MJ&\6]]##G*U$=SVC@AVPQ$24VYX;@(U2%<,T:(<HMCOAS#>M@TG5;IY)JO^
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MADDFF6T[S=> >D'C7&QJK;<C,601<3B?BNU9GX('.:_B(QX '22]UV3R.I(
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M)H9+6"!Y\.[J"G4]]8[5P4.;),"GRU?XS>;!)J_EMS!.KYA*_A3.%\]AW,U
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MT">T?A%!.2PD^L0%8K.\Y"ZX"@+&-T]*!R[7P%?WYDC>$,^2SS"@],IA%J]
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MYV8SN1GE2=72*YO(F1M3L(L=B1NY=(-,+L_B^FXL\.P![?\5;3_N;YR5@CS
MX[<[7ZP?4$7W6]AS+,X&.N+STX7:A!7"AM[<-M.X7@2%*1KRW9J)$VOYUHS7
M B!T"R-K!?S1,+^*'::-,KM;LM=D82GG2H[0\C(DT&+%>9SVCPD)M2+_Y$G4
M-:Z_I:D^DFDC.D0CE2+4,:^>*NCRXJ9\5U3VDZ286C$R71H;UEH]*\2.Y15C
M\!(XJ)Q$9B12T!#X:XE&^'$N;/V*/@VZL^S-$YI^IB#<!AZZ%@7V6"YD7'?&
MI!83KCN-(55TJ<6';F ;+C"EL9V4[,.&"+3.M<^]!DJJ"FUOK*15#&!(/=(-
M;TMU_YX."+8TUBYS*[H>?\:,;ZE+2*085A6;D0"=8FGY+%W@HS%&MSS8>"D6
M@N[W&5DLV!K^2"@9E8GXUF?); ]YJ=3VF^095D%4&NB!\%^]\V6,BAPM?"S]
MQ447$LIT*K7A'4&V<;P;UZAJ"/A485"ZJ?2FV_%J;]";I7 Y+Z>YM)G<83WV
MH9UX-*3+-%<W8..(LWB7>98C&=<PBFQZ''A7^X$_45SQF(YN>_C)+*N%<RR<
MM39!NQU)6%Y&;K5]Q6(>@ZQI(M4N%+EVY@4;^U'OAE4"OA&\I7Y_$=PC#E7V
M0Y9LVARXPD0Z/T=!XS&"=_K3%L>K4!'D5)>O%)7OZ"-TNZKB*?68MI,"+02Z
M)HP9]2E704@27?SH5;F1EKB)2PS5A$K")Y&H$<ZR1_D:N KU!D)E1)SJRBF_
MGT?DB%,.X3GM$R1:R+%6]T@7F'[+I.^ FGJJTVLD0K ;P(*[/-1.NJ*PO(L0
M']A!ID];CHKUV% Y"B86.%5Y/*)EFI<E]FIQFIWP6U 6"-MU>DI+&W>DCV/;
MML"CD\2>=9$X<X/A-.!P0BXB1MH20&3Y!!7@^%$1,RQ)TBDC#%]AWR+.+V;C
MIW3'WPA[0ZDY.$"3MBB4$\":&#-+SI\Z[LT<*[Y?2[XKL$6WWRE/9N#>16_8
MVUC!&S\\'#N8S>"CO-MY6[#Y@ET_A?!%<#8JDAF;M$=Y,#&7E/H2')P],WV^
M:'!C[3I]GD7RZHGM[C9BBD_#0OJZ>ZBZGPVBJIE-+.2M/*=;Q:ZE5MV0:@I
ML/9&T9^R@M?:$Z60%,Y8+1Y<$4&WY\8Y>NW-[6+X2G6-F"TF6VD"KJH@#(XY
MW&$LX\-)!\*^2F\ (LWWX^P?'Q!?LWN_!P2YB#%\?AY]CM6T2H:JB:=FP0/\
M5)!B6NQ0IT7CB&[IV2(J9<;VGMTQM8H^VQ.E1A2;B5*-F&M0+C9BH2'!$JH^
M5'($](MI#-XRZ!W;BO9M59*R=DB7)_3E$/&W!?U96AW\N8NWGW9_C9NB<J&X
M 2%^( -YZ=_H_D8ZFQ-?Z81/0Y:)T35FM9&LQB1-F]<?NL'":_22="R1PW!6
MFS9-%O2<D886F*!/C8I( KRE+G[4]\^T\7/;![KNH-_K"0DGJHOK/-&]X!B"
ME%A7N0+_Z?0QB,/Y%/X_ 9V<2#@ C(CI$%1?C+I?<:;#D(8/ [EQ$]*))%V:
M>@&';H=0GUK)$BX92+P^IG8%.;8,EAX%+:W?"*<(]Z7[R#GR$4EZ*3R[04;D
ME A%34HD\"B-HX+BK];\'V65D&$IQ24:#]QK6;,UDWAY:/B["=:'E12XDM#I
M'ABOM % K-T\_U36$7,4ED0OD(O549]:<S:"(?Z*X5?<UXQTY$+P4"+?P*Y
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MH:3:\[#X)K.G_GC!:_ \8"7FA24Y1JC2-3?FS+PSIS2J"IC9Y2#NTIJ693I
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M2#I7)*<+SOZK?Y'AA&@P-)D9W98*O- LHI1H9,GEB3'E)!AL2:="!TEMBYQ
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MC#FU?F8*7E4F+2((*&CV6&[LI9+Z*1C%F$=&B6M=YXS2X3VF#6OR$%LV@9$
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M_IE!\ 0?J&VV@F:]#HYP8%)5\3Q8Y."]J+QL\*BUO)5,H*UXQ&64=H4*3Z0
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M:J0V0FUY+C=%1ZWIGK-9NC!5DU8=XT:PGU-]R[RT?^5&6N/&>C8>2[!Q%U#
MIKCXO=$;'P5<%/S</_PP"$X'>X.#GP?[83/-N3[%*K,RI225JB@J8EU<5(IW
M6>7?@V*W0F9]D3[_=L@LW\A_N1Q"HRRJ&R ]*YL!]+QO#[UI_G"-P^C8E3>K
M>G?_O*][K[YTDUCA2:N2_9'4S<\YN<0R'1WI_AW2^^N>,Z"6"??'<'=AY-^C
M)F/_!VS:-Q_D$;_?_V)4-@COZDWP[G<?J_QV-_8ZE>E0UQ]BJ^^#E7['FZW$
MW^-6_[&W_<YN?*L\I!.<^STE%-N#:G3[I[O'^[]0(._=^?O#G?\/4$L#!!0
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M:D^Q[TG5QF@QLWT[BS,*^4_4Z6<(@TD&7.3P!"4!/$^><$D_;&]O#,F3.S'
MHL/WIPX8Q=233>(Q(NTMN&RWDT9794]#ZZW5AAR%$*G-*%6U>4H>Q@DYFQN+
MM5DB:.0(-I:7LP1NR'_X.;O)6&(*)DQM+ %9 ! [&R4S>%TWL</^%AJ-+.IV
MTSQ'07D>O-LZ!G=WPRJA45^YU>,:$:)4F2&)CD PRU@DNR:_&_U)9?B* <=S
M<H_6X9<:]R'S.GZAN 7554ZL3K]F-<SQ.U/CH;UOYU(3Y:/2F749V5]8;_5!
MPK4 ,S*;V%QV+8E2\[*:I4N=:LNVYG,$Q,T)R.4%UCJ51*<>&Z;#QBVHYP=%
M>RU%NWMS15O5F@8T.-6EN"P2CB;A_A(SLN/5'."0N$[@^[O3W(;F1KOM4=[>
M\64[=,/=_\>-=W]IM(C,%"Y8&<8,.$0Q1Q#"V,GR6*X)QL!&&).B\ PEC2O=
MP*!V\41DBK[=%;ICKI."WHEY'CAENG0T"FJ>RY;=\P?>_U8X\A:+':X7+UD'
M'/?D 0<G.+@G?T8<W V#)_<A@ .VKA@>8%I;,3@'N,*%V%PWCCV-Q,@>8;UU
M1;E;@V*8)$6I020F>#M*HWFIY!G9:]AO#"VBI&[(=SO<]"BK(Z8:D%R\GB%X
M!K-6ST"%?,ANM]!5E#<C 1RCN*TL)P5?%>Q.SZE14*FEH+/&E;<Z'QM#R@;4
MK':"I#]_\60[B+:FZ)XT=:<"^_+IB^W'06O_JAYX<T.B\M'9WG_OXH+P+_^H
M^[XV-2_S=#Y%38!X 5P\*%X\+T1ABJ$WDMBTMEI!5WQ;;SU.L $6/6ID#;5L
MI#&XL"L =?XCT ^:\$N4FB><VT<,2<C,7N5<O'Z<9)^"(ZQ0MXL)5)D/8A_.
MHTPRK%0#Q&5=!+,2KS<G#,YDGHUTK0(_!;_E1?68_-.\K"B>!_K9,+83 J^M
MO,SUFD."8FR,>V0)8'J4]#5F,4MI3Q0EA0 8I>R9U'QS@)W"#_8YYQ*[>!:3
M+*&ZC0CT/JR.\(0<ICC/<RR0BM#Z<(*I8E),H]^X!0&&:%$KQ49NZ H*V@H[
M'<CU'CIG*EDH-(G<7*>\9LPE(FC<P&HEDREUVBJ&.HL2'X-UR_"H;U$QF%@(
M>MUUR-N7U@F>8"4.7Z43QE$"/+)4EK5JBS5$6;>C9=E75!'=CM81S0T,[U1%
M=#NW3]?KJXANITU'K,1<WYZ* .MIJ8X([EY%=#OKZXC@SE0$H>_6UA'!':B(
M;N?Z.B+X2BK"+K']JIG\&X*S#^I9QJB(%;8YD?1"0YA = 9"DG '7,Q(8" C
M3>$,%5-] MIBX[E&<WJEW!PUQEI .CZ,BVQ)]\:$>>)%"[JC@C4)D(/YINE.
M)I+B G9H_2*'<EA(](FK@V9YR5TE%6J.;VYU?T2$X?WCKFM%!*T0WO6QWJNB
M$DNC@<UAWNVMY\\:([WJ:\XKCWOJ O2+W\=8^)*,2A_@:\6W;C/>;O7J?+S>
M3CU^OO7#'>#2%;ML/5V781X3^9(M#0;9%_1V$]SJ \8N78Q('>DV0M.PZ: :
M^)Q![7"[-X(%,_Y;9#7E21@J3!4YZAP+B@);C!4Q-GF5G"1*F;DI@?$2>UX-
MA?Y\&*4DF-2O24"1/; ?TVG/X9"?8:L14^(AO4CQ?G(1WA[QX@A=QA)XN!C;
MGXT34*3<>BVP\I/['_M[;L=NMZQ0F9@16 0H8#$=RH%ADL9R0])ZDLCM]PP.
M!QZY$H<S0V5?:=+9I?#U7:/,-W>V6Q-Q0];);J_I.M0NP%[GB<+RR%W=WZN6
M3&+]8_9]BFC^8C.?;-+U=M=R.U^GVXAL1/!24_)4?-WE6R&]T%3]7 E67??H
MTZ4,F$&,5/_V$;E-"LYD$.2RA9J]V.!2UZFKLLA/0/O\&6KKM99<Z'94=B&O
M8XNLWN\.68AQ3,,"P=1*!9K!P;N[(*MM!/.S=JXU.E^G4,(4R+97B;0\URZR
MZ'8^N\KB<Y:RP7D7XS^W]#$/E#2M]7'?8F%J,5C+LQJ@^:9;YH0*.U'HJJ9'
MJL$,<0BAM8<QT,1IEL;PX;QHLZC\9AF*T:S4D\+>F]P3 N@*^1$*G]S-W?LO
MZC[2:[8/IN5B:E4TMI:G;-"Q178DIX73\AID7#O[/:>;A/#[D@TC"*3-$>#P
MI*4.GP@8&HU$74SCJ*D&VMHPUI9*F16+"IT5,4< O31$2>%\L#LJ$(#2SVGR
M[WDR)F31.)I&Y^(W48@ P1/@/D5IM6#!$T>PVW_9";>WMQO2FM8+.'*EVS&A
M#H/X:(?ZK(T" 0']EYUM"J$Z,Q.2;(0;(,[W7Q[3)0Z^0CT*.!=XO5D,+2%T
MSU"C_EMZ]^8?8\U[A7U)$'U3OX[5H &<P#.$7>"[48*=6QW"-CHG\,:ZB"'R
MZX#Q"%$B)@H\$P+?^$W_] R/VWD133&L8'K(.L4D>/NR%L"U>A5N!?V2FZ,S
M6C<,[#XP+'9!7?ERM[D13*GD=&FN9U\M1.\>-95T86\IKPO59GM*&.&,R30B
M.\X)\OE"KAXLHNZWJLXE6RK-&@K&OIISOR,V_7UQ+=I\"WRL#@4U>!8''MK!
M*D"J5WUQ>6M-,(8*"HEE;!*"BJSBF&Z'X!BF&,R'6#@6GP>&7Z72FG4",+!Y
M\2!&I9>-=.V15/FZYB&6WJG2%OQXGAE7RA,M6)TGD5*O.C@4-6X_G4GJA!'E
M1,"Y0= *;B49PH)$L4(F#_RM^-MB\!.4X-0&L-LYH:VT>-DW(V!;C:_<X.Z*
M4[S:IFB&+%*M, 5TUS$H,M<#LTO]N"\!E2F0?O+4TQ^4$:Z]C'701D\?T$:"
M-GKZYT0;W2\>O[ZPNS2R#H59G)415VJ@QMF=+S8/J'C_#0@XK,,'H8&K2!=*
MXJP14?3F-YGN[:(;3368[_!(2<(=2=D6:*9; UOKU1 -\\O8D="1#?_T^VDL
M%=.2X;0<$ G!V!$@N^]F0GJ\R#]Y1L0&EUK3U ;)$Q(=HI%*<.IP6$]5ZGDA
M5;XK'HU)4DRM\)FN@@[5-#B=<52MX6$IRC;"L"9P4#F)S,B+H"$FV!*H\"-@
MV&\7O1UT=-G/1XM?;#S768T">^P*,JX[W$[K1-?3QFCK+%HH[[J!;;B6F.8%
M4J82>U_0.C=^[S504A7C>_/LK%D=AM0CW66X5/?OZ5BA3VV3.#;68OP[YJM+
M7?PC=<^JBI"LA2EV$9BE"WPTAN\:XY .R-FFTE5DL:"UT2Z=$DJB96*KZ+-D
MMH>"BCB8E%O48/U*I6$JB*O6.U_&:+NB/L0J;UQT(5%.IR@?WA$$'(?"<8VJ
M^H-/%<:KFXJFNAVO:@H=78JD\W*:J]C)4=;C#]J)1T-8].0)(Q5P?1B:N<BS
M',FX@9UH3#L+[VH_)BA66CRFH]L>F#++:N$<"\"NO2X,*U"B]2)R&RM4+.8Q
M_)HF4J=$06UGI*AQF?1N6-7^6\$;ZL@7P3WB4"5&9,FFHX4K3*3==A0T'B-X
MI[_L<"@+%4%.+1B4HO)# (B)KZIX2HV][7Q!"X'P]UC%8<4G273QH]?E1EKB
M-BXQ5"/J"%U%HD8XJ[D8C]I H3*J!$=CR2F_=4ODB%..[CF=,B20R&%8]T@7
MF)G+I,6$FGZH,V\D0K#QPX(;>M1.NJ*PO(L0']A!!M1:OKGUV%#YQB9*.%4I
M/J)EFI<EMN5Q^MKP6U!^"!,VGM+2G@SIX]BV+?#H)+%G723.O%(X#3A\BJO#
MD;8$;UD^200X?E3$C+N53,L( UO8HHI3C]GX>[KC;X0<HJP='*!)6WS*23!-
MC)DEYT\=]V:.E7!'2RHLL$6WWVI?9F'>;J]K8X>N#5RY5^:P90T?YMW.FX*M
M&&S/*?0O@M-1D<S8L@7/9V(N*?4E.+AW9CJ[T7RNVG7Z6(L UK.=_5HB["8H
MJ):^;O.I[F<CP6K6$\MZ*Q/J=BG0PJMN3S6%WEB)HP9(6<]K)8K"2 J3K%8>
MKJ2@VW.K)+WVY@9!?*6Z1JR7Q$(2^.5Y<-KA#F,97TRJ$#97>C\0:>Z P:_)
M6?>%P:W8UAY0YAP>T.V<1;_':EX9 ^_$<[.0!'[62'$O-B?4HG)$M_1L$Y5=
M8_O/[G):1;_;DY9&%)Z,4@T1;U V-KBA(143JA9D<A;TBVE$X3(@86@*C?WT
MO']:E^?^Y33QMP7]65JC%+@5M9^A?XD=-%7:%#<@Q ]D "/]F_*B.N\37^JI
M5 WY* ;BF-5&LII*EPLVKS]TX^57Z#7I<+K*4-=M5?2DD886[J!//:I(%+RA
M!H[4\M%T<'0[1[KNH=_F"PDGJHS+;\T@>^DN4^4*Q*@SS2 7YU/X_P1T="+A
M 3 JID-0A3': HHS'88T?!C(C9M 423RTM0+0'0[!&'52I=0UD#BS3$UGLBQ
MS:]TFVCI^D=X2[CO1)*"^$JMV"4>HB$SB4K$U28E$GB4QE%!*0A[ KQ8*61H
M"@Q:HYM[+6NV9E NSX[<"4IR7>P=2K=[!+Z[M#,(>V#6TE8 V7;S_%-9A]E1
M=![]0VY @"K6&GT2#/%7#-GBYG:D-O%,((9*)!V8&B@.2IW0XK/56)0,<N2+
M6(/W9RL_9R7KI &>/:0!) WP[$^9!K@WG'X-4'G<0_/"CUUJ1?3.0#+;@,$H
ML@1.@1^VBAM6:O5NM/6$I!4O)'R^%8VS[]>8'W6BW*$2;/#BVDKB.+N$<63A
MRM_0=B5?9"VD1 @+:D5PW_,U.@L[^+Z-*C^/23_KF*@7PNB#=9)B)*CTA]OR
M6$4LQZA(@9#9<PZN#KHYS7=5$^^:4=/F48QW5$^P@3[]JBJ2(3=-.N9Z$#N,
MW@/=H5I@9#':5=0].+\B9PZCT:4&.^SJ*X*C*QGT:+&5TTN+NCCW.%ZH 8^Z
M2E%&6>CX6,A^X,J I[_&1C,3U:U%&?RH@0@:6L'#94R\E2-!S<]?LT=(,SR3
M\T%2R<442U1Q#'>$AQ7*LH#PN"R_W6U;F-,:O5OK9((Y+C^>Q. Q"HIE>69P
M.BT'%*$F*PAO^-0C/WS11'T-%39+*V3V;FD%[.?6XM!/@=7*@%YWM>:0M0\M
MWEACJ'##: EK3')/82LIAAI9OPZXZ$BOOK"CZE&:G^=S;?U;O](=-55T]'IT
M[G96$AKG%6")7N"(O40U<_,#U:%JTVL=6*=\"L&>9I&T1)(#5FOU492.L&N>
MN*DMU64[3[! 4K;(F>9[DX&0(7I_=)1 K)IJ-Y]ZM6285+,ZD3T_$:/ZBZKW
MDH-+&3+,I;2\F^[DT/AR)AT,AB#:]B@NX/UTX05I9?2NB0IVIF"(&=VT1ETB
M!BX#-+NM*B7&T,IY25;?8U4Q+J7>CLRB6$PL40>[UU%I8T\I@UW$0BZL4*D(
M!VX?SP;V=O4@TF"U).]Q>8@*$;7(,&]]%K_*8<!]",9).2KBIJ:,:N-H#D:I
M9%0C0MS/]TD)55U_.X0E?KDQ98-;)&RW\SF4)5P[8;(E%:K1Z&O8$*$?*%+[
M1*9EEMMI.;CC)=K+"U$=!',@:VX$I(A&"QU2=.CLX%<X 62S=Z0C\FR982YY
M7I*QAF<FAA//DZL)-F)MM6[,<+="3Z)C5CIVA;1.,KTXE1$T!H6-'F\V+D)C
MZ'/,+E6H?=M>6WT?SEU-3'VZ5,754F9V\3T#S),1J[T,\PE<8R\2D/.[<A<Y
MEB%#Y:7,A .T(>,'X-Y4[L7WG@,KC?"V^1PVBF*,WK0HK)/;\W_G)5O=GU#K
MC*J.8T+0/&6-2/VN9=19))52)/R9>CKZ1@61HP:;#INRS=ZP KM<0AT=O%\J
M#4TS>E"3-EP+EN!V#=CJ=@XXPD6S/J[-@HVGK,7WHXUO-L2P0K#5.@Q-HMCS
M36OVUWH&;IF(4F8(6&2W/J#2M&M1X,IJ7\*>NX6-6BY2[7(.3<BG6\^??Q>H
M%L'7X44'Z;!D$YR\SAK>E)6#\/2+#8(00(*</;_EQ)1@7U1T%#.T1OZ^CO=J
M8()BN=4DJ5L!M\X]DXSZ[E->1R&[G@OIUSI+L)0[(?UR__4B3CW[@5JABL]0
MFRCB6(Y28IZC+3VG+4);<K$5]#-K<\3F6D4_'4@?QJ9JVAY:],/.J],/QZ_+
MZM7W^"=U'[?0EPH0LVQNSUGS2^DQ*>;0P$N553&7AL0)8J"F-.>MVZ%\G,3O
M37I>%3W"KQ+8'A2TF*^I%FU]0QU*$ARJH!FWWHIDUKHVR#C,WU,0-)64C%69
M.64P<?58YJSB$\0IZ/4A1Z_:"'%/C=>0%USA]BD.]'A6)/I,B *'*(LQ>$1S
M>0NJG"X4:@?(#9H]Y:DO?N#.."F\-W8I>=UK\;>)F(UK-_44SF['E-7>287,
MO8D6FY&1+9U[U\E]_/"0^Y#<QP]_RMS'*A[Z6OD-:T#I$SV@="\NJ,2VKV%*
MY6?/*OUJQ+CYU!9K<JG8#?L)@3/'[$R>SM*DN=3-'3D*"B2-:]Z]98/PI)(9
M-G*(.*G-4VWB;.SD:T@UH-N,(15C':,FL/Y-,[V-B8*6M6MW%E945@"=N?Z;
MA>"V['J!N0:)=6>OA]T&Z4GILGB9)V-E+8WS^; *K8R6/7M^B15;'S3<:&!I
MX%]/QH"4\R%3KUS'"0!M35%GA&05-=,QY&D.&)0<XB ZIT !8?\RE0Y=(PQ_
ML6>%?-&[QL/+*=:O-CV=QDE<]I@>)8^B&Z4XUXZJ<R5PU%9QXA)X)'/7>9&^
MIT;^I1-DXG"* R(T>#8';Q@Y0$L-L"1W+"ZB*K=:>*SE&FUPJH;\1K1MY\5"
MDT05@+39\%)6Q$#-2XK5.@$W#KYF.06GKKVRY9Z#>:B)N>E;4M2-2JK62W@9
M#!Y8=FR4RK/45 6>T*7\IM9V(;7$$]^9\U7!/&-;<\S>A 5-)="BBX&QS&GL
M9*?72+U63 NF.F4X04;=5\AU)X!<8QS< O64C>/"./IHR4='&!(V\3JKLEP@
M6EFMGXK($PZ#L2#0'3&+>-,]CG^X*7LW788U,?%T/BS)S*M4>7AP!$1'[%W9
M6OQH^+"YTIO8C^+%+!(L?6NKC'-JM! J 9I3.\^T9.A$6TJ2=I87:@/ 2P[=
M7DGWAM!)#RB +KMA%0$9<>Y$I'QCX7[%V9Q?[7:(?9:)PLJ)2QVKQ9@Z^X;B
M/;N@W8.S1R/!AVHD/7G+0! #UU!>H_>PT!,SWM=U9/W(5%')8\=>>1/64U%@
M9#VH -_%R$[*%8( :1>B&RHIC6LNQHJ[;/_7EL'L]%MQ2YY(ZV>UUPBS])J4
MDHY<YJK7<J3X IN)@767Z<+&<XZ4JK@3!<%5,[KFW<FI&AB#8_2]=^/0/-V.
MFS:S9AO]"ZYT<J/&#2NF\,BRU08;JV#<HMCJ *5ZSJ_;,25.JO,/2W*R@.J/
M%U@'SXY6$E]8DD.**JNS,K7FG3FE7%5\S2XD<9?6M"S378I>=X.JI.NX $W4
MUJP0^@CR=LT;X#VJ9S#]RY>DC1(ZM4CA8;P@2U]Q@9"1PHE #35$E%@3-Y=2
M2>B4R)X)SIUWA'$#G[LK?[Q9MS==AC7N]KC(0?VB0MJWG456P/L\K,^,?/4[
M8[D.:^BW[RQEVC=HLX+._E2U#ZXYLHZY1L(>F0&48(Q2P=&\HC2L"RB NU).
MA8YO5LV+S/9_'(_:PB\UBWI^!]O;GDB#N5)YTSY6(#1& 'X[8S5CEA1IHL!-
M9IA G$S"FF,7FKH$E-"T#^<4!@X)P\(E*=;'UE*D<,'J;M +G-)_FP5<&\(V
MI,A(9C/=;9=JI_)0 !IX@H!ZVAHXKI*']KJ4[,<RBSKLQBG>(Q/#NI^@F+ +
M^RIS8YFV6V5MF)S6;9D;C1BZ=21>M[/4W)@L-3=JI+^Y+8&-[-<W)H)66\)L
MIJ3\ZNRQTH)0W++,A/@_=GETB^W@//4&ED.WLY;I$%S+<O!/BF\WR-*:884"
M[FP'E=2LAR6/Z^E0AX5EJO^HU7+@+CIFL5X[:[NCY!<Q)+J=N[ D<)[?;;2U
M_UK+6"?)]>-#DDN27#_^*9-<]X3';VPMCXVU_&:>C:.I%%J?&3M*97NNF>$)
M]2QZ'7#G\N9TP4 "]2^RI!!0AC8T ^08&FG9<N#=<="RY K'F%(7C->D Z)C
MJ;:)3O@$>A89)7;U3*@;C'M%LXL 8W<)F!7%HM>Z9'<YZ/6'01J3#9@F(RPH
M1U&MRIQ#74@<,JB,W4?;/= C1U!/49\C#,(B+2L&\4OYNN4X8*\@(5L$IG@A
M8+0FZJF<CK4+]@N%5KN:":VR4DU2)TSF6&%,^9,-A2]6G1<LI*-+9VK$K:Q(
MM]D(&U"6T50SE61^ 5L$&,0T"[.6!$]+5!\45JQU[X1:4.16J!+UMVIM+M.'
M3/+-6M.4C<HH"YYM:[25G1'Q\XSX VE3;OWB,N?I4&"JZ19G(_ZE2D=ZR2G*
M@=W-Z:FY7?")/_<*KF'?47_6U.";#PQN[SPM<Y6Q,EM3VVX#LK7RGB8?07VE
M5%D.G5IKH]E27KVWG$)<DWH$N5I%/I(R\^F40>[&"^:WU6>'.G:[;NEP7F(.
MM722* T%1#@FTVXFY&Y(6-L.]J(WR8LVPK#11^XIJ+Y]+/%JQJ7#Q:J>\ K-
M29SY0(9G\^42GRA7'XRV;&+1_-.&$X+1@/8C$FR0]VV[^)8&"SP%YF8,)!7
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MIHF0;T)9/9],,V-U9RI:5+VW;?/0-Y?J?9JXX1,!QZ\R796#ZU,-)N"X729
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M]NS]N]?_'U!+ 0(4 Q0    ( +B (UNR<E >)@,  -\+   1
M  "  0    !A<VYS+3(P,C4P.3 R+GAS9%!+ 0(4 Q0    ( +B (UM\HT[
M_0H  '^&   5              "  54#  !A<VYS+3(P,C4P.3 R7VQA8BYX
M;6Q02P$"% ,4    " "X@"-;S[G;$E<'  #25P  %0              @ &%
M#@  87-N<RTR,#(U,#DP,E]P<F4N>&UL4$L! A0#%     @ N( C6_Z,B3*Y
M(P  N\$  !@              ( !#Q8  &5A,#(U-3<U."TX:U]A8W1E;&ES
M+FAT;5!+ 0(4 Q0    ( +B (UM]PG*^9RL  "74   =              "
M ?XY  !E83 R-34W-3@P,65X,3 M,5]A8W1E;&ES+FAT;5!+ 0(4 Q0    (
M +B (UOV_50D:%   #Z< 0 =              "  :!E  !E83 R-34W-3@P
M,65X,3 M,E]A8W1E;&ES+FAT;5!+ 0(4 Q0    ( +B (UN8T;AN5%   ,F8
M 0 =              "  4.V  !E83 R-34W-3@P,65X,3 M,U]A8W1E;&ES
:+FAT;5!+!08     !P ' .P!  #2!@$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>ea0255758-8k_actelis_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="asns-20250902.xsd" xlink:type="simple"/>
    <context id="AsOf2025-09-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141284</identifier>
        </entity>
        <period>
            <startDate>2025-09-02</startDate>
            <endDate>2025-09-02</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-09-02" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-09-02" id="Fact000004">0001141284</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-09-02" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-09-02" id="Fact000010">2025-09-02</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-09-02" id="Fact000011">Actelis Networks, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-09-02" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-09-02" id="Fact000013">001-41375</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-09-02" id="Fact000014">52-2160309</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-09-02" id="Fact000015">4039 Clipper Court</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-09-02" id="Fact000016">Fremont</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-09-02" id="Fact000017">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-09-02" id="Fact000018">94538</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-09-02" id="Fact000019">(510)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-09-02" id="Fact000020">545-1045</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-09-02" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-09-02" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-09-02" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-09-02" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-09-02" id="Fact000025">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-09-02" id="Fact000026">ASNS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-09-02" id="Fact000027">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-09-02" id="Fact000028">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-09-02" id="Fact000029">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
